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Many of the things we need can wait. 
The child cannot. 
Right now is the time his bones are being formed, 
his blood is being made 
and his senses are being developed. 
To him we cannot answer “Tomorrow”. 
His name is “Today”. 
 
- Gabriela Mistral, 1948 
 
 
 
 
 
 
 
 
 
 
 
 
 
I dedicate this work to past, present, and future children  
suffering the silent epidemics of micronutrient malnutrition 
  
 
 
 
 
  
ABSTRACT 
Selenium is an essential element that is found in food sources such as meat, fish, and cereals. 
The essentiality of selenium was demonstrated in the 1950s, and the interest in its health 
effects has been growing ever since. Deficiency is common world-wide, particularly in 
Europe and south-eastern Asia. It has been estimated that 0.5-1 billion people could be 
selenium deficient.  
Previous studies regarding health effects of selenium have focused on the impact of 
deficiency for the risk of cancer, cardiovascular disease, and decreased fertility and immune 
function. Lately, the importance for brain function has also become the focus of many studies 
assessing potential protection against cognitive decline and certain neurodegenerative 
diseases, such as Alzheimer’s and Parkinson’s disease. However, little is known about the 
importance for early-life development. In particular, the role of selenium in cognitive 
development has not been studied, even though the brain is one of the organs with highest 
selenium priority at deficient intake levels. Therefore, the overall aim of this thesis was to 
assess whether selenium status in early life is important for cognitive development.  
The studies included in this thesis were based on data from a large mother-child cohort in 
rural Bangladesh. The cohort was nested in a randomized food and micronutrient 
supplementation trial that was established in 2001-2003, called the Maternal and Infant 
Nutrition Intervention, Matlab (MINIMat). Women were recruited to this nested cohort early 
in pregnancy (at pregnancy testing), and donated urine and blood samples continuously 
throughout pregnancy. The subsequently born children were divided into two groups for 
different outcome assessments. For cognitive assessment, children were followed-up at 1.5, 5, 
and 10 years, while assessment of immune function and various effect biomarkers was 
performed in the other group of children at 4.5 and 9 years of age.  
To evaluate the role of selenium in cognitive development, concentrations of the element 
were measured in urine and blood from the pregnant women, and also in blood, urine, and 
hair from the Bangladeshi children at different ages (n=223-1408). Results from the group of 
children who donated blood, urine, and hair, demonstrated that also hair selenium could be 
used for assessment of selenium status in the present population. Using multivariable-
adjusted regression analyses, we found that adequate selenium status during pregnancy 
seemed important for the children’s cognitive development. Children born to mothers with 
higher selenium status performed better on the cognitive tests at 1.5, 5 and 10 years of age. 
Also the selenium status during early childhood seemed to be important for the cognitive 
abilities at the 5- and 10-year follow-ups. There was an indication of an upper limit for the 
positive association, in line with the narrow therapeutic interval for selenium.  
Assessment of influential factors for the selenium biomarkers indicated that exposure to 
arsenic and cadmium (both strong pro-oxidants) changed the distribution of selenium 
between different biological compartments (or vice versa). Importantly, malnourished 
  
children seemed to retain more selenium, supporting that the regulation of selenium occurs 
through changes in urinary excretion also in children.  
To conclude, this research, based on different biomarkers of selenium status and 
comprehensive testing of cognitive abilities in large samples of children at 1.5 (n=729), 5 
(n=1260) and 10 (n=1408) years of age provides substantial, new evidence of the importance 
of adequate early-life selenium status for brain development. Similar studies in other 
populations, as well as research on efficient ways to improve inadequate selenium status 
without risking selenium toxicity, are warranted.  
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1 INTRODUCTION 
Micronutrient malnutrition is often referred to as the “hidden hunger” because the 
consequences are not always visible. In the past, this has mainly concerned four 
micronutrients: vitamin A, zinc, iron, and iodine. However, other micronutrients with 
prevalent deficiency world-wide, such as selenium, are also of great importance. It has been 
estimated that 0.5-1 billion people world-wide are selenium deficient (Combs 2001). The 
main areas affected are Europe and large parts of south-eastern Asia (Fairweather-Tait et al. 
2011). However, there are also seleniferous areas in e.g. western U.S., Canada and parts of 
China and Russia, where the selenium intake can reach even toxic levels. The interval 
between the essentiality and toxicity of selenium is rather narrow.  
The focus of this thesis is on the potential importance of early-life selenium status for 
cognitive development. Although many have studied the association between selenium status 
and cognitive decline in elderly, less is known about the impact of selenium for cognitive 
function earlier in life. This is particularly important since adequate nutrition during 
pregnancy and childhood is crucial for normal brain development, laying the foundation for 
the development of cognitive skills, motor function, and socio-emotional skills throughout 
both childhood and adult life.   
2 BACKGROUND 
2.1 SELENIUM IN HUMANS  
Selenium is a non-metallic micronutrient that was first discovered by the Swedish chemist 
Jöns Jacob Berzelius in 1817. The essentiality of selenium was demonstrated in the 1950s 
(Schwarz and Foltz 1957), and the interest for its positive health effects has been growing 
ever since.  
2.1.1 Selenoproteins 
Selenium exerts its biological effects through different selenoproteins. In total, 25 
selenoproteins have been identified in the human proteome (Burk and Hill 2015; Kryukov et 
al. 2003), but not all of them have been functionally characterized. In the selenoproteins, 
selenium is incorporated in the form of selenocysteine (Figure 1), in which the sulfur atom of 
cysteine is replaced by a selenium atom. This results in a lower pKa and higher reactivity of 
the functional selenol group, compared to a thiol group. All selenoproteins contain one 
selenocysteine residue, except for selenoprotein P, which contains ten such residues. This 
selenoprotein constitutes the major circulating and storage form of selenium, and seems to 
play a role in antioxidant protection (Burk and Hill 2015). 
Several of the other selenoproteins also exhibit antioxidative properties, such as glutathione 
peroxidases (GPx) and thioredoxin reductases (TrxR). The main reaction catalyzed by GPx is 
reduction of hydrogen peroxide to water and glutathione disulfide, while that for TrxR 
involves reduction of the redox protein thioredoxin, as well as of other endogenous and 
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exogenous compounds (Lu and Holmgren 2009). Another family of selenoproteins is the 
deiodinases, which regulate the activity of thyroid hormones e.g. through catalyzation of the 
conversion from thyroxine (T4) to triiodothyronine (T3, active form; Papp et al. 2007). Many 
other biological processes have also been linked to selenoproteins, such as biosynthesis of 
deoxyribonucleic triphosphates, regulation of apoptosis, and immunomodulation (Roman et 
al. 2014).  
2.1.2 Sources and chemical forms 
Food items rich in selenium include Brazil nuts, fish, offal, eggs, meat, and cereals 
(Fairweather-Tait et al. 2011). The amount of selenium in different crops is highly dependent 
on the selenium content in the soil, and thus, the dietary intake varies widely between 
different geographical regions (Burk and Levander 2006). Selenium content in the soil largely 
depends on the type of underlying bedrock, with higher selenium levels in soil derived from 
e.g. shales, sandstone and limestone (Fairweather-Tait et al. 2011; Hatfield et al. 2016). 
However, the level of selenium also varies depending on natural (e.g. volcanic and biotic 
activity) and anthropogenic (e.g. fertilizers) sources.  
Areas with unusually high soil selenium include parts of the U.S., Canada, South America, 
China and Russia (Fairweather-Tait et al. 2011; Hatfield et al. 2016). Such areas may also 
have elevated levels in drinking water, although in general, intake of selenium from water 
and air is often negligible. In contrast to these areas, parts of Africa and Australia, New 
Zeeland, large parts of Europe (including Scandinavia), and other parts of China and Asia, 
have much lower levels of soil selenium (Fairweather-Tait et al. 2011).  
The uptake of selenium in the crops is not only influenced by the total amount in the soil, but 
by a combination of the chemical form of selenium and the soil conditions (e.g. pH). Selenate 
(+VI oxidation state) is taken up more rapidly than selenite (+IV oxidation state) in most soil 
conditions, partly because selenite may form complexes with e.g. iron in acidic soils (Reilly 
1996). In the plants, the main form of selenium is selenomethionine, followed by 
selenocysteine and selenite or selenate (Figure 1). However, in some selenium accumulating 
plants (e.g. Astragalus bisulcatus and Stanleya pinnata), the main form of selenium has been 
found to be methylselenocysteine (Freeman et al. 2006). In meat, the major forms are 
selenomethionine and selenocysteine, although the ratio between these depend somewhat on 
the form of added selenium in the feed (Hatfield et al. 2016). These forms are also present in 
fish, and the selenium concentration has been found to be somewhat higher in marine fish 
than in freshwater fish (Cappon and Smith 1981). However, it was recently discovered that 
the major form of selenium in tuna is selenoneine (Yamashita and Yamashita 2010), which 
was later also found in other types of fish and as a metabolite (Se-methylselenoneine) in 
human blood and urine (Klein et al. 2011).  
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Figure 1. Selenium species claimed to be present in urine of humans or rats. Adapted from  (Francesconi 
and Pannier 2004).  
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2.1.3 Metabolism 
In nutrition, the term “status” refers to a nutrient that is biologically active or potentially 
active. This means that both the selenium pool that is metabolically functional, as well as the 
pool that can be readily mobilized to functional forms, are included in the term “selenium 
status”. Thus, selenium status is the product of intake and absorption, tissue distribution and 
retention, and metabolism (Combs 2015).  
Selenium is generally efficiently absorbed in the lower part of the small intestine. This is 
believed to occur through multiple membrane transport mechanisms, several shared with 
those for sulfur (Fairweather-Tait et al. 2011; Roman et al. 2014). There appears to be no 
homeostatic regulation for the uptake, and the absorption varies between 70-90% of the 
intake depending on selenium species (Burk and Levander 2006). Once absorbed and 
transported to the liver, the conversion of dietary selenium (mainly selenomethionine, 
selenocysteine, selenite and selenate) to selenoproteins involves many intermediate steps for 
which the details are still unknown. Selenomethionine can be metabolized in a similar 
manner to methionine, and may be randomly incorporated into methionine-containing 
proteins (Burk and Levander 2006; Fairweather-Tait et al. 2011). Other selenium species are 
reduced to selenide, which is incorporated into selenoproteins, transported to other organs, or 
excreted (Figure 2). The reduction to selenide requires glutathione, and this is a non-
enzymatic process. However, the redox potential is too high for selenate, why it must first 
undergo enzymatic reduction to selenite (Ogra and Anan 2009).  
The incorporation of selenium into selenoproteins (in the form of selenocysteine) is 
dependent on several factors. The UGA codon, usually signaling protein synthesis 
termination, is also the codon for selenocysteine. However, the incorporation of 
selenocysteine into the protein requires a selenocysteine insertion sequence (SECIS) that 
forms a stem-loop structure in the 3’ untranslated region of the mRNA (Berry et al. 1991). In 
addition to the SECIS-element, tRNA charged with selenocysteine, a selenocysteine 
elongation factor, selenophosphate synthetase, selenocysteine synthase, and a SECIS-binding 
protein are also necessary for the selenocysteine biosynthesis and insertion (Kryukov et al. 
2003).  
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Because of the toxicity of even moderately elevated intake levels [around 850 µg/day for 
adults (Yang and Zhou 1994)], it is essential for the body to be able to excrete excess 
selenium. Selenium is methylated via the one-carbon metabolism and excreted mainly in 
urine, and to some extent breath [mainly at high exposure; Figure 2 (Fairweather-Tait et al. 
2011; Jackson et al. 2013; Roman et al. 2014)]. The main forms of selenium in urine are 
mono-, di-, and trimethylated selenides (Francesconi and Pannier 2004; Suzuki and Ogra 
2002), but many other species have been detected in urine either from humans or rats (Figure 
1). The monomethylated species include selenosugar 1, 2 and 3 (Francesconi and Pannier 
2004). Dimethylselenide is excreted through breath, while the trimethylselenonium ion 
(TMSe) is a constituent of urinary selenium. It was long believed that TMSe was a major 
SeCys 
Intestinal absorption   
SeMet 
SeMet SeO
3
2-
   SeO
4
2- 
SeO
3
2-
   SeO
4
2-
   
 
SeCys 
SeCys 
SeCys 
H2Se 
Selenium-
containing 
proteins 
GS-Se-GS 
    
 
 
GS-Se-Sugars CH3-Se-Sugars 
CH
3
-Se (CH3)2Se (CH3)3Se
+ 
Urine 
 Breath 
Se-Cystathionine 
 
Se-HomoCys 
SeMet 
Se-Adenosyl-Met 
Se-Adenosyl-HomoCys 
Trans-selenation pathway 
  
Selenoproteins 
Figure 2. Scheme of human selenium metabolism. Various selenium species are absorbed and 
transported to the liver for metabolism and production of excretory metabolites as well as 
selenoproteins, which are then excreted or transported to various tissues, respectively. Adapted from 
(Fairweather-Tait et al. 2011; Jackson et al. 2013; Roman et al. 2014). Abbreviations: (Ch3)3Se+, 
trimethylselenonium ion; (CH3)2Se, dimethylselenide; GS-Se-GS, selenodiglutathione; GS-Se-
Sugars, glutathione-seleosugars; H2Se, hydrogen selenide; HomoCys, homocysteine; Se, selenium; 
SeCys, selenocysteine; SeMet, selenomethionine; SeO32-, selenite; SeO42-, selenate. 
Methionine cycle 
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urinary metabolite only when selenium intake was above nutritional requirements. However, 
this metabolite is excreted also at normal intake levels, and we recently showed that the 
production of this metabolite appears to be genetically influenced by polymorphisms in the 
INMT (Indolethylamine N-methyltransferase) gene (Kuehnelt et al. 2015). Formation of 
TMSe also increased the total urinary selenium excretion. Surprisingly, the prevalence of 
these polymorphisms was very low in the Argentinean Andes (essentially no producers of 
this metabolite compared to 1/3 in Bangladesh), despite better selenium status in Argentina 
than Bangladesh. In the mentioned study, children had lower %TMSe compared to adults, but 
data is generally lacking regarding potential differences in selenium metabolism between 
children and adults. 
2.1.4 Biomarkers 
Methods for determining selenium status have been extensively reviewed (Ashton et al. 2009; 
Combs 2015; Diplock 1993; Neve 1991; Van Dael and Deelstra 1993), but still, many 
uncertainties remain, particularly regarding children. The total concentration of selenium in 
plasma/serum can be determined with good sensitivity. It responds fairly quickly to selenium 
supplementation or changes in dietary intake, and is therefore the most commonly used 
biomarker. The biological half-life of selenium differs depending on selenium species, 
compartment, and dose, although whether this differs between ages is less studied. In general, 
plasma/serum selenium concentrations are said to reflect intake over the past week or weeks 
(Neve 1991). However, the concentrations may be influenced by inflammation (Oakes et al. 
2008), and also by pregnancy due to the plasma expansion (Faupel-Badger et al. 2007). 
Concentrations below 40-60 µg/L are often considered deficient based on reduced plasma 
glutathione peroxidase (GPx3) activity (Fairweather-Tait et al. 2011; Neve 1991). However, 
the concentration of selenoprotein P saturates at higher plasma concentrations (80-125 µg/L; 
Burk and Levander 2006; Hurst et al. 2010), and has thus been suggested as a suitable marker 
for selenium status together with, or instead of, GPx activity and plasma concentration. 
Selenium in whole blood, and especially erythrocytes, is considered a more long-term 
biomarker for selenium status due to the incorporation of selenium during synthesis of these 
cells and their long life-span (~120 days; Neve 1995; Thomson 2004). Concentrations in 
erythrocytes are often correlated with those in plasma (Madaric et al. 1994; Stefanowicz et al. 
2013), although the response to changes in selenium status is generally slower than that for 
plasma. About 15% of the erythrocyte selenium is incorporated into glutathione peroxidase 1 
(GPx1), and there is a strong correlation between the total selenium concentration in 
erythrocytes and the GPx1 activity (Stefanowicz et al. 2013). However, the GPx1 activity has 
been shown to saturate at higher concentrations, while the total erythrocyte selenium 
concentration still continues to rise with increasing intake. This is because the remaining 
~85% of the erythrocyte selenium is bound to hemoglobin (Oster et al. 1988). Due to this 
binding, it has been suggested that the erythrocyte selenium concentration should be adjusted 
for the hemoglobin concentration in order to account for variations in hematocrit 
(Stefanowicz et al. 2013; Vitoux et al. 1999). As concentrations in plasma have been more 
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widely used to assess selenium status, there is no accepted reference range for selenium 
concentrations in erythrocytes, either for adults or children.  
Other proposed long-term biomarkers of selenium include concentrations in toenails 
(Longnecker et al. 1996) and hair (Lemire et al. 2009; Yang et al. 1989). However, there is no 
accepted cut-off for selenium deficiency or toxicity based on concentrations in hair or nails, 
partly because few studies have compared these concentrations to those in plasma, 
erythrocytes, or whole blood. In addition, many studies include small sample sizes, and there 
are also large differences in methods used for hair sampling, washing, and analysis, which 
may be the underlying reasons for the demonstrated huge variations in measured 
concentrations of the same hair sample (Seidel et al. 2001). Finally, there are wide variations 
in reported hair concentrations across studies with normal selenium intake or plasma 
concentrations (Lemire et al. 2009; Martens et al. 2015; Yang et al. 2010), suggesting that 
there could also be a difference in tissue distribution depending on unknown factors, although 
the analytical errors are seldom known. 
Several studies have proposed that urinary selenium is a useful biomarker for assessing 
selenium status since urine is the major route of excretion (Longnecker et al. 1991; 
Longnecker et al. 1996; Yang et al. 1989), but there are many uncertainties remaining also for 
this biomarker. Urinary selenium reflects very recent intake, and is therefore considered a 
short-term marker. Main forms of selenium in urine include the selenosugars (1-3) and 
TMSe. Besides the genetic influence of INMT (Kuehnelt et al. 2015), regulating the 
formation and excretion of TMSe, there is probably also genetic variation affecting the 
formation of selenosugars, which also show marked inter-individual variations (Lajin et al. 
2016). In addition, it was recently discovered that Se-methylselenoneine was present in the 
urine of eight volunteers, and that this metabolite constituted 24% of the total urinary 
selenium for one of the volunteers (<10% for all others; Lajin et al. 2016). Measured 
selenium concentrations in urine should be adjusted for dilution, or preferentially, measured 
in 24-h urine samples (Robberecht and Deelstra 1984; Sanz Alaejos and Diaz Romero 1993), 
although this is not easily achieved in large study groups. Similar to the variation in hair 
concentrations at comparable plasma/serum concentrations mentioned above, there seem to 
be marked differences in the ratio between plasma and urine between studies (Table 1).   
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Table 1. Studies including measurements of both plasma/serum and urinary selenium in healthy 
children and adults. 
Country 
 
Reference 
 
n 
 
Plasma 
or Serum 
(µg/L) 
Urine 
(µg/L) 
Ratio 
Plasma/
Urine 
Comment 
Brazil Martens et al. 2015 41 107 270 0.4 Supplemented children 
Brazil Martens et al. 2015 41 84 40 2.1 Non-supplemented 
children 
Turkey Mengubas et al. 1996 61 42 25 1.7 Healthy children 
Germany Jochum et al. 1997 Not stated 69 14.8 4.7 Healthy children 
Poland Blazewicz et al. 2015 40 107 58.1 1.8 Non-obese children 
Czec Rep. Kvicala et al. 1999 119 59 11.2 5.3 Healthy children  
China Lei et al. 2016 35 39 7.74 5.0 Children in non-
endemic areas 
USA Longnecker et al. 1991 142  198 169 1.2 Adults in high Se area 
As the interval between selenium deficiency and toxicity is rather narrow, the difficulties in 
comparing biomarkers between studies raise concern. This is particularly troublesome 
regarding deficiency and safe intake levels for children, since selenium deficiency may affect 
child development, and the cut-off for excess intake may be lower than that extrapolated from 
adults.  
2.1.5 Dietary recommendations 
During the 1930s, there was an outbreak of a fatal cardiomyopathy in Keshan, China, and it 
was not until almost 40 years later that it was discovered that the Keshan disease was induced 
by a very low selenium intake, <12 µg/day (Keshan Disease Research Group 1979). After 
this discovery, a minimum intake of 20 µg/day in adults was suggested as sufficient to 
prevent Keshan disease. Still, an intake of 15-40 µg/day (previously reported in New Zealand 
and Finland) has not been associated with clinical deficiency symptoms, although it is 
associated with decreased GPx activity. In turn, this may be related to a lower protection 
against oxidative stress, and a potentially increased risk of cardiovascular disease (Duntas and 
Benvenga 2015). Therefore, later recommendations of intake were based on optimizing the 
GPx activity, and the recommendations vary between 30-85 µg/day depending on population 
category (age groups, pregnancy etc.; Table 2) and country (Rayman 2004).  
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Table 2. Recommended intake (µg/day) of selenium by population category (Institute of Medicine 
2000).  
Abbreviations: AI, adequate intake; EAR, estimated average requirement; RDA, recommended 
dietary allowance; UL, tolerable upper intake level. 
The recommended intake during pregnancy and lactation has been estimated by adding the 
normal requirement for adults to the amount of selenium acquired by the fetus, and the 
amount transferred through breast milk. Based on a proposed fetal demand of 4 µg/day, the 
recommended intake for pregnant women is 60 µg/day. During lactation, the average loss of 
selenium via breast milk is about 14 µg/day, resulting in a recommended intake  of 70 µg/day 
(Burk and Levander 2006; Institute of Medicine 2000). For infants and children, the 
recommended intakes have either been extrapolated from adults, or estimated based on 
concentrations in breast milk (Table 2). Thus, there is a need for more data on the actual 
requirements for children at different ages. 
Symptoms of selenosis (selenium toxicity) in the seleniferous area in China have been 
observed at intake levels above 850 µg/day (Yang and Zhou 1994). Based on those data,  the 
Institute of Medicine has calculated a tolerable upper intake level (UL) of 400 µg/day for 
adults (Institute of Medicine 2000), which is slightly higher than that calculated by the 
European Food Safety Authority (EFSA) of 300 µg/day (European Commision 2000). Thus, 
the safe range is rather narrow (Figure 3).  
Life stage Rationale EAR  RDA  AI  UL  
0-6 months Human milk content   15 45 
7-12 months Human milk + solid food   20 60 
1-3 years Extrapolation from adults 17 20  90 
4-8 years Extrapolation from adults 23 30  150 
9-13 years Extrapolation from adults 35 40  280 
14-18 years Extrapolation from adults 45 55  400 
>18 years Maximizing plasma glutathione peroxidase activity 45 55  400 
Pregnancy Accretion of selenium by fetus + normal requirement 49 60  400 
Lactation Loss of selenium in milk + normal requirement 59 70  400 
  10 
Figure 3. Estimated average requirement (EAR), recommended dietary allowance (RDA) and 
tolerable upper intake level (UL) of selenium for adults (Institute of Medicine 2000). The narrow 
interval between essentiality and potential toxicity is marked in green. 
The transfer of selenium across the placenta is high, resulting in ratios of maternal/cord blood 
selenium commonly around 1 (Chen et al. 2014; Rudge et al. 2009). However, the transfer 
has been shown to differ somewhat depending on selenium species, indicating that specific 
transfer mechanisms are involved (Santos et al. 2017). The correlation of total selenium in 
maternal and fetal cord sera in the study by Santos and coworkers was rS=0.56, p<0.001 
(n=83), although it was much lower for selenoprotein P (rS=0.25, p<0.001). The average total 
selenium in cord serum was about 80% of that in maternal serum (56 and 69 µg/L, 
respectively), while the concentration of selenoprotein P was only 66% of that in maternal 
serum (28 and 42 µg/L, respectively). Similar serum concentrations of total selenium have 
been found in Swedish mothers (late pregnancy; 72 µg/L) and newborns (53 µg/L; n=74; 
Osman et al. 2000). There are no reports of teratogenicity due to maternal selenosis and no 
overt toxicity in infants with high (not toxic) intakes of selenium through breast milk. Thus, 
the UL for pregnant and lactating women is the same as for adults in general. For infants, the 
proposed UL is based on concentrations in breast milk from women in seleniferous areas with 
no apparent signs of toxicity either in the child or mother (Table 2). As this UL is similar to 
that for adults per kg body weight, the UL was adjusted to older children based on relative 
differences in body weight. 
However, several recent supplementation studies in adults have found adverse effects (mainly 
increased risk of cancer and type 2 diabetes) in the groups receiving doses of 200-300 µg/day 
(Vinceti et al. 2017). Thus, it is likely that the upper limit for safe intake of selenium will be 
lower in future recommendations. In addition, the assumption that maximized GPx activity 
would indicate adequate selenium supply has lately been challenged (Vinceti et al. 2017), as 
there is little evidence that this is actually beneficial to human health. Instead, it has been 
proposed that part of the increase in enzyme activity with increasing selenium intake is due to 
compensatory mechanisms, as selenium in high concentrations may also act as a pro-oxidant 
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(Lee and Jeong 2012). Therefore, Vinceti and coworkers argue that the recommendations set 
by WHO (i.e. intake of 25-34 µg/day for adults, based on health indicators) should be 
promoted.  
2.1.6 Health effects 
Regarding the health effects of selenium deficiency, focus has mainly been on cancer, 
cardiovascular disease, diabetes, inflammatory disorders, and male fertility, but the results are 
often conflicting (Fairweather-Tait et al. 2011; Rayman 2012; Vinceti et al. 2014a; Vinceti et 
al. 2018). Among children, deficiency has mainly been associated with Keshan disease 
(cardiomyopathy) and Kashin-Beck disease (osteoarthropathy; Ge and Yang 1993).  
During pregnancy, low selenium status has been associated with preeclampsia (Xu et al. 
2016), and it has also been suggested to play a role in e.g. premature birth, low birth weight, 
and neural tube defects (Bogden et al. 2006; Mariath et al. 2011; Rayman et al. 2011). 
However, population-based, prospective studies assessing the importance of selenium during 
pregnancy for various health outcomes are scarce. Recently, the interest in beneficial effects 
on cognitive function and neurodegenerative diseases in elderly has increased (Cardoso et al. 
2015; Solovyev et al. 2018). As such diseases are often associated with increased oxidative 
stress (Barnham et al. 2004), it can be hypothesized that selenium could be preventive 
through its involvement in various antioxidative systems. For the same reason, it may be 
hypothesized that selenium could be protective in populations highly exposed to pro-oxidants 
such as arsenic, cadmium, or mercury. Little is, however, known about the importance of 
adequate selenium status in utero or early childhood.  
Chronic toxicity following excessive selenium intake (selenosis) has been observed in 
seleniferous parts of China (Yang and Zhou 1994), with symptoms of toxicity including hair 
and nail brittleness and loss, gastrointestinal disturbances, rashes, garlic breath odor, fatigue, 
and irritability. More recent studies have also suggested an increased mortality rate and 
increased risk of certain types of cancer and type 2 diabetes at intakes even around 200-300 
µg/day (Vinceti et al. 2017). However, data regarding adverse health effects in children is 
lacking.  
2.2 THE DEVELOPING BRAIN 
2.2.1 Cognitive development 
Cognition refers to all inner processes of the mind that result in “knowing”. It includes all 
mental activity, such as attention, memory, planning and reasoning, problem solving, and 
creating (Berk 2013). Early cognitive development is a predictor of school progress, and it 
has been shown that enhancements in education, of girls in particular, result in improvement 
of child survival, as well as future health, nutrition, and education. Through this chain of 
events, children without the possibilities to reach their full developmental potential further 
contribute to the transmission of poverty through generations, thus restricting also future 
children from reaching their full developmental potential (Grantham-McGregor et al. 2007).   
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After conception, the nervous system starts to develop very quickly, beginning with the 
neural tubes (Berk 2013). During the embryonic period (2-8 weeks of gestation), the 
foundations for all structures of the nervous system are laid (Figure 4). Production of neurons 
occurs at a very high pace, and at the end of the second trimester, the majority of the millions 
of neurons are in place and start to differentiate. About half of the brain’s volume is made up 
of glial cells, which support and feed the neurons and are responsible for myelination. These 
cells multiply rapidly from the 16th week of pregnancy through the second year of life, and 
the brain weight increases tenfold from the 20th week until birth due to the increase in neural 
fibers and myelination. The process of cell division slows down through mid-childhood, but 
accelerates again in adolescence. At birth, brain weight is nearly 30% of the adult brain 
weight, and increases to 70% at age 2, and 90% at age 6 (Berk 2013).  
In the third trimester, the cerebral cortex, the seat of human intelligence, enlarges (Berk 
2013). The cerebral cortex surrounds the rest of the brain and accounts for 85% of the brain 
weight, including a great number of neurons and synapses. This part of the brain is the last to 
stop growing, and therefore it is also sensitive to environmental influences for a longer time 
than the rest of the brain.  
The order in which different cortical regions develop corresponds to the order of which 
different capacities emerge in the infant and growing child. The cortical regions with the most 
extended period of development are the frontal lobes. The prefrontal cortex lies in front of 
areas controlling movement, and is responsible for consciousness, attention, inhibition of 
impulses, integration of information, planning, and problem-solving. From the age of two 
months, the prefrontal cortex is more active. During preschool and school years, it undergoes 
rapid myelination, formation and pruning of synapses, followed by another period of 
accelerated growth in adolescence, when it reaches adult levels of synaptic connections 
(Figure 4). At the rear and the base of the brain is the cerebellum, which is involved in 
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Figure 4. Overview of periods of human brain development, including the period particularly sensitive 
to nutritional insult (FAO/WHO 2002; Georgieff 2007). Adapted from (Thompson and Nelson 2001). 
  13 
Hypothalamus 
Thyroid gland 
Peripheral tissue 
Thyrotropin-releasing hormone (TRH) 
Thyroid-stimulating hormone (TSH) 
T4 
T3 rT3 
IDI 
 IDII 
IDI 
 IDIII 
Pituitary gland 
balance and control of movements. Located in the inner brain is e.g. the hippocampus, which 
is active in memory and spatial functions. This part of the brain is subject to rapid synapse 
formation and myelination between the ages of 6-12 months, which is the time when recall 
memory and independent movement begin.  
Even though the prenatal period and the first years of life may be particularly active periods 
in terms of brain development, regions involved in higher cognition continue to develop into 
adolescence (Thompson and Nelson 2001). From mid-childhood to adolescence, connectivity 
among different regions of the cerebral cortex increases (Berk 2013). As a result, adolescents 
evolve and enhance their cognitive skills such as processing speed, memory, and attention.  
Brain development is regulated by nutrients and growth factors both during fetal and early 
postnatal life. Because of the rapid brain growth towards the end of gestation, the brain is 
particularly sensitive to nutritional, as well as toxic, insult between 24-44 weeks after 
conception (Georgieff 2007; Figure 4). Still, early insult may affect the cell proliferation, and 
thereby cell number (Winick and Rosso 1969), as well as the programming of tissues and 
functions (Barker 2007). Severe malnutrition during such early periods commonly result in 
miscarriage or physical birth defects (Berk 2013). Later nutritional insult instead affects 
differentiation, and thereby size, complexity, and synaptogenesis. 
Of particular importance for proper brain development are the 
thyroid hormones, since they regulate expression of critical 
neurodevelopmental genes (Rovet 2014). Selenium is an 
essential component of the iodothyronine deiodinase 
enzyme that converts thyroxine (T4) to the active 
hormone triiodothyronine (T3) through removal of one 
iodine atom. More than 80% of T3 is produced through 
this conversion in peripheral tissues. Thus, selenium is 
important for proper thyroid function (Figure 5). In 
addition, thyrocytes produce H2O2, which is then reduced 
to H2O by GPx and TrxR in order to protect the thyroid 
gland from oxidative damage (Duntas and Benvenga 
2015; Kohrle 2015).  
Figure 5. Scheme of the hypothalamic-pituitary-thyroid axis. 
Selenium is incorporated into iodothyronine deiodinases (ID) I-
III, which convert thyroxine (T4) to the active form 
triiodothyronine (T3; IDI and IDII) or the inactive form reverse 
triiodothyronine (rT3; IDI and IDIII).   
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2.3 SELENIUM AND COGNITIVE ABILITIES 
Selenium levels in the brain have a tendency to be preserved under conditions of dietary 
deficiency (Burk et al. 1972), suggesting that selenium is of importance for maintaining brain 
function.  
2.3.1 Experimental studies 
In the brain, the highest selenium levels have been found in gray matter areas, especially in 
the putamen and the pituitary gland (humans), and the cerebellum and cortex (mainly rats; 
Chen and Berry 2003). Selenium appears to have an important role in the protection of 
neurons, as selenoprotein P (major contributor to selenium content in the brain) has been 
shown to enhance neuronal survival and prevent apoptotic cell-death in response to oxidative 
challenges (Takemoto et al. 2010). For instance, selenoprotein P and other seleno-compounds 
have been shown to protect motor neurons through interactions with a potent oxidant, 
peroxynitrite, generated in these cells (Sies and Arteel 2000). Knock-out of the gene encoding 
selenoprotein P in mice resulted in ataxia (Schomburg et al. 2003), and also in loss of motor 
co-ordination in mice given a selenium deficient diet (Hill et al. 2003). However, this was not 
evident among the knock-out mice who received the recommended (or higher) concentrations 
of dietary selenium, implying that the brain can take up also other forms of selenium. In 
addition to selenoprotein P, knock-out of deiodinase II (responsible for activation of thyroid 
hormones) in mice resulted in elevated thyroid-stimulating hormone (TSH) and T4 levels, 
and a small growth retardation (Schneider et al. 2001). GPx1 knock-out mice exhibited 
increased sensitivity to neurotoxicants (de Haan et al. 1998), and embryonic knock-down of 
GPx4 revealed signs of developmental retardation and massive lipid peroxidation (Ufer et al. 
2008). The activity of GPx1 seems to be higher in glial cells (mainly astroglial cells, forming 
the outer layer of the blood brain barrier) compared to neurons (Damier et al. 1993; Power 
and Blumbergs 2009). This suggests a double-layer protection through selenoproteins formed 
by e.g. selenoprotein P (inner layer) and GPxs (outer layer; Chen and Berry 2003).  
In addition to motor functions, selenium compounds have been reported to enhance the 
cognitive abilities tested by the object recognition test, the Y-maze test, and the Morris water 
maze tests in rodents (Rosa et al. 2003; Souza et al. 2010; Stangherlin et al. 2008; Watanabe 
and Satoh 1995). In the study by Watanabe and Satoh, the selenium-dependent effect was 
restricted to the female mice. Further animal studies in rodents fed a low-selenium diet have 
shown increased sensitivity to drug-induced nigrostriatal degeneration (Kim et al. 2000), and 
a preventive effect of selenium supplementation on dopamine loss, degeneration of neurons, 
and lipid peroxidation (al-Deeb et al. 1995; Imam et al. 1999; Zafar et al. 2003). Moreover, 
administration of selenite to rodents has resulted in improved cognitive scores and reduced 
neurodegeneration (van Eersel et al. 2010).  
Selenium supplementation during gestation has been associated with increased concentrations 
of selenium in the brain of the subsequently born pups (Bou-Resli et al. 2002), who also had 
increased levels of T3 and T4. In addition, prenatal selenium supplementation was associated 
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with a reduction in anxiety-like behavior in young pups, and increased cognitive functions in 
adulthood (Laureano-Melo et al. 2015). However, at toxic doses, selenium supplementation 
during gestation has been associated with impaired learning and motor function in the 
subsequently born pups (Ajarem et al. 2011). 
2.3.2 Adults and elderly 
Since selenoproteins appear to have important functions for neurons, astrocytes, and 
microglia, decreased expression could be associated with cognitive decline also in humans. 
Indeed, poor selenium status, assessed as plasma, erythrocyte, or nail concentrations, has in 
several cross-sectional studies been associated with cognitive decline (Gao et al. 2007; Rita 
Cardoso et al. 2014) and reduced motor function and muscle strength in elderly (Beck et al. 
2007; Lauretani et al. 2007; Shahar et al. 2010). However, the study by Rita Cardoso and 
coworkers consisted of a small sample (27 Alzheimer patients, 31 elderly with mild cognitive 
impairment, and 28 controls) and merely compared plasma selenium concentrations across 
the groups. The study by Gao and coworkers used selenium concentrations in nails (long-
term marker; n=2000) of lifelong residents of the same town or village. Therefore, the authors 
suggest that the exposure reflected lifelong selenium status.  
A 9-year longitudinal study (n=1389) also showed an increased probability of cognitive 
decline in elderly who had a marked decrease in plasma selenium concentration over time 
(Akbaraly et al. 2007). This study concluded that selenium status decreases with age, and that 
this may contribute to the decline in neuropsychological functions among aging people, 
although the possibility of parallel events cannot be excluded. In the same cohort, it was also 
shown that low baseline plasma selenium, as well as elevated levels of oxidative stress, were 
associated with an increased risk for cognitive decline, and that the association between 
oxidative stress and cognitive decline was stronger in the group with lower selenium status 
(Berr et al. 2000). In addition, supplementation with one Brazil nut per day [can contain 3-36 
µg selenium/g nutmeat (Chang et al. 1995)] for six months has been shown to increase 
selenium levels as well as cognitive functions among elderly with mild cognitive impairment 
in a randomized control trial (Rita Cardoso et al. 2015). However, studies on associations 
between selenium concentrations in different tissues or blood fractions and Alzheimer’s or 
Parkinson’s disease have been inconclusive (Chen and Berry 2003; Solovyev et al. 2018).  
Better selenium status in adults (measured in plasma) has also been positively associated with 
motor function (Lemire et al. 2011), although another study found no correlation between 
selenium status and performance on neuropsychological tests (Kunert et al. 2004). In addition 
to poor selenium status, selenium intoxication has been associated with signs of motor and 
sensory abnormalities (Vinceti et al. 2014b; Yang et al. 1983).  
2.3.3 Early life 
Little is known about the importance of adequate selenium status for fetal and child 
development, especially for the development of the brain, which continues well into 
adolescence.   
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The first clinical reports linking poor selenium status and neurological disorders in children 
suggested that a type of infant seizure was associated with low selenium status, and this 
condition could in fact be treated with selenium supplementation (Ramaekers et al. 1994; 
Weber et al. 1991). However, until the work in this thesis, there were only two small cross-
sectional studies regarding the association between selenium and cognitive function in 
children. In a Bangladeshi study of  arsenic exposure and motor function among 8-11-year-
old children (selected based on low or high concentrations of arsenic and manganese in 
drinking water), low concentrations of selenium in blood were associated with poor motor 
function in one of the sub-tests (Parvez et al. 2011; n=304). No beneficial effect of selenium 
on IQ was reported in a study on Inuit preschool children, designed to evaluate potential 
adverse effects of lead, mercury, and polychlorinated biphenyls (PCBs; Despres et al. 2005; 
n=110). However, the blood selenium concentrations in the Inuit cohort were exceptionally 
high [average concentration corresponding to intake above the UL of 150 µg/d for 4-8 year 
old children (Institute of Medicine 2000)]. In addition, the aim of the study was not to assess 
selenium, this was merely included as a covariate for which the estimate was not reported. In 
an additional study on the same study population, the authors reported an inverse association 
between child blood selenium and latency of visual evoked potentials (Saint-Amour et al. 
2006), although the analyses included only 72 children. Even the lowest blood selenium 
concentration was high (158 µg/L), implying that a non-linear association would probably 
have been impossible to observe.  
Besides the few studies on concurrent selenium status and children’s cognitive abilities, there 
was one Chinese study that assessed the impact of selenium status on early postnatal 
neurodevelopment. The authors found a positive association between cord serum selenium 
concentrations and scoring on the Neonatal Behavioral Assessment Scale at 3 days of age 
(NBNA; test of neurodevelopment) at concentrations up to 100 µg/L (n=927; Yang et al. 
2013). However, at higher concentrations, the association turned inverse (n=80). Thus, prior 
studies on this topic are very limited. 
2.4 INTERACTIONS BETWEEN SELENIUM AND TOXIC METALS 
It has been suggested that selenium could protect against the toxic effects of 
metals/metalloids such as arsenic, cadmium, and mercury. The toxicity caused by such 
elements occurs largely through generation of reactive oxygen species (ROS; Valko et al. 
2005), and the suggested mechanisms for the protective effect of selenium include 
antioxidative protection from selenoproteins such as GPx and TrxR. Also sequestration into 
inert conjugates to be excreted has been proposed. Even though such complex formation 
could potentially contribute to lower metal-induced toxicity, this could also result in 
functional selenium deficiency. 
2.4.1 Arsenic 
Arsenic is a toxic metalloid with severe health effects such as cancer, cardiovascular diseases, 
liver and kidney disease, and diabetes mellitus (Abdul et al. 2015). Human exposure includes 
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two main chemical forms of arsenic: inorganic (iAs; e.g. arsenite and arsenate) and more 
complex organic compounds (e.g. arsenobetaine and arsenosugars). The organic forms are 
mainly found in seafood, and are considered much less toxic than the inorganic compounds 
which may be present in drinking water and certain food items, such as rice and algae (EFSA 
2009). Rice easily takes up arsenic, as well as several other metals. The level of exposure 
depends on geological conditions and dietary patterns, and elevated exposure is frequent in 
areas of Bangladesh, India, China, and Thailand, partly due to elevated concentrations in 
ground water and partly because of the high rice consumption (IARC 2004). However, 
elevated well water concentrations may be found also in many other countries. 
Once ingested, iAs is methylated through the one-carbon metabolism, with S-Adenosyl 
methionine (SAM) as the methyl donor, to methylarsonic acid (MMA) and dimethylarsinic 
acid (DMA; Vahter 2002), which are excreted through urine together with remaining 
unmethylated iAs. The relative amounts of these arsenicals (%iAs, %MMA, and %DMA) are 
often used to assess methylation efficiency, which differs largely by individuals and 
populations due to factors such as genetics [mainly polymorphism in AS3MT], sex, age, 
pregnancy, and dietary factors (Antonelli et al. 2014; Gardner et al. 2012; Li et al. 2008; 
Lindberg et al. 2008; Pierce et al. 2013; Skröder Löveborn et al. 2016). A more efficient 
methylation (higher %DMA in urine) has been associated with lower toxicity in adults, 
compared to those with lower %DMA and higher %MMA. There are also major differences 
between animal species (Vahter 1999). 
An antagonistic relationship between selenium and arsenic was first observed in 1938, when 
it was discovered that selenium-poisoned rats could be treated with arsenic (Moxon 1938). 
Later, it was discovered that arsenic and selenium could form a complex (seleno-bis [S-
glutathionyl] arsinium ion; [(GS)2AsSe]-) that has been found in the bile of rabbits and rats 
(Gailer et al. 2002; Levander 1977), and that has been shown to assemble in erythrocyte 
lysate in vitro (Manley et al. 2006). In these animals, the formation of this complex has been 
shown to facilitate the excretion of each respective element. Based on these studies, it has 
been assumed in multiple studies and reports that such a complex is also formed in humans, 
although in fact, this has never been shown. In addition, the main excretory pathway for both 
arsenic and selenium in humans is through urine and not bile, why a decrease in toxicity 
through such a complex is questionable. Besides [(GS)2AsSe]-, selenite and arsenate have 
been found to interact directly and form an insoluble selenide complex (As2Se) in the 
lysosomes of renal cells (Berry and Galle 1994), but again, this has not been identified in 
humans. 
Since selenium is also methylated through the one-carbon metabolism, this is a potential 
pathway for interaction between these elements. Indeed, it has been shown that exposure to 
selenium decreases the arsenic methylation efficiency in vitro and in mice (Kenyon et al. 
1997; Styblo and Thomas 2001; Walton et al. 2003). However, the few available 
epidemiological studies are conflicting. A positive association between urinary selenium and 
arsenic methylation efficiency (%DMA in urine) was observed in two cross-sectional studies 
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on pregnant women and other adults in Chile and Taiwan, respectively, although neither 
group reported adjusting the urinary concentrations for variation in dilution (Christian et al. 
2006; Hsueh et al. 2003). In the study from Taiwan (Hsueh et al. 2003), the authors did not 
find any association between serum selenium and the arsenic metabolite pattern in urine, and 
neither did a study on Bangladeshi adults (n=287; Pilsner et al. 2011) or on pregnant women 
(Li et al. 2008). Still, the Bangladeshi study reported a positive association between plasma 
selenium and %DMA in whole blood, which, however, is difficult to determine. We found a 
positive association between selenium concentrations measured in erythrocytes and %DMA 
in urine, while the association between urinary selenium and %DMA was inverse, in 488 
Bangladeshi children (Skröder Löveborn et al. 2016).  
The inverse association between urinary selenium and %DMA could suggest a competition 
for methyl groups (SAM) and/or glutathione (used for reduction of both elements) between 
selenium and arsenic (Zeng et al. 2005), which may in turn influence the distribution of each 
respective element between different biological media. In support of such a competition, we 
recently found that the production of TMSe was associated with lower %DMA (both 
metabolites measured in urine) in 223 pregnant women from Bangladesh (Skröder et al. 
2018). It should be noted that these elements are not major consumers of methyl groups, 
especially not during child growth, which requires a considerable expansion of protein and 
transmethylation products such as creatine and phosphatidylcholine (McBreairty and Bertolo 
2016). Still, a decreased ratio of reduced:oxidized glutathione has been associated with lower 
arsenic methylation efficiency and increased arsenic retention (assessed as increased 
concentrations in blood) in Bangladeshi folate-deficient adults, i.e. with potentially decreased 
SAM activity (Niedzwiecki et al. 2014). This implies that arsenic exposure could also 
increase selenium retention, since the methylation of selenium that precedes excretion is also 
glutathione-dependent. Yet, the enzyme converting oxidized glutathione to the reduced form 
is GPx, a selenoprotein of which the expression increases with higher selenium intake, 
particularly at low to normal intake levels (Whanger et al. 1988). In addition, higher plasma 
selenium has been associated with a higher ratio of reduced:oxidized glutathione (Galan-
Chilet et al. 2014).  
Finally, it has also been hypothesized that selenium may interact with cysteine residues on 
AS3MT (Sun et al. 2014). The modified structure would then inhibit the enzyme activity, 
which would decrease the arsenic methylation efficiency, resulting in higher %iAs and 
%MMA, and lower %DMA. We recently found that the association between polymorphisms 
in AS3MT and arsenic methylation efficiency was not present among women who are 
producers of TMSe, however, we do not know if this was due to inhibition of AS3MT, 
altered expression of AS3MT, or competition for methyl groups or glutathione (Skröder et al. 
2018). 
To summarize, it is still unclear how arsenic and selenium interact in humans, especially in 
children. It might occur through several mechanisms depending on e.g. chemical form, dose, 
or genetics. Also, it is unclear what the health implications of these seemingly complicated 
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interactions may be. Protective effects of selenium, defined either as high levels in blood or 
as supplementation, on arsenic-induced skin lesions have been indicated in a few studies 
(Chen et al. 2007; Yang et al. 2002), while others have found that the risk of arsenic-related 
skin lesions was not associated with the blood selenium concentration (Chung et al. 2006). 
Despite a potential protective effect concerning skin lesions, it cannot be taken for granted 
that selenium protects also against other effects of arsenic.  
2.4.2 Cadmium 
Cadmium is a toxic metal that we are exposed to mainly through food, in particular cereals, 
seafood, and offal (Jarup and Akesson 2009). Absorbed cadmium accumulates in the kidney 
where its half-life is in the order of decades. Therefore, chronic cadmium exposure is 
associated with health effects such as renal tubular dysfunction. In addition, cadmium has 
been shown to adversely affect the bone, and exposure is commonly associated with 
osteoporosis and thereby increased risk of fractures, as well as increased risk of cancer, 
cardiovascular disease and mortality (Akesson et al. 2014). 
Animal studies on interactions between selenium and cadmium have shown an antagonistic 
relationship between these elements, where selenium can enhance the antioxidant defense 
system and decrease the oxidative stress caused by cadmium exposure (Zwolak and 
Zaporowska 2012). Indeed, cadmium has been shown to reduce the GPx activity in tissues 
including the brain, which could be counteracted by selenium supplementation (Whanger 
2001). Such an antagonistic relationship between selenium and cadmium was first observed 
in 1946, when the authors found a protective effect of injected selenite in animals exposed to 
a lethal dose of cadmium chloride (Tobias et al. 1946). Later, it was also discovered that 
injected selenium could be protective against testicular cancer caused by injected cadmium in 
rats, which was also confirmed by others (Whanger 1985). Still, several of the studies also 
found an increased concentration of cadmium in testes and blood with increasing selenium. 
Besides the mechanism of an enhanced oxidative defense, a cadmium-selenium complex with 
a molar ratio of 1:1 has been shown to form in vitro, and this complex was also able to bind 
to selenoprotein P (Sasakura and Suzuki 1998). However, this has not been shown in humans, 
and the toxicological importance of such a complex is unknown.  
Finally, some observational studies have found a stronger association between cadmium and 
adverse health outcomes in population strata with the lowest selenium levels (Skröder et al. 
2015; Wei et al. 2015), while others have found no clear protective role of selenium against 
cadmium-induced adverse birth outcomes (Al-Saleh et al. 2014). 
2.4.3 Mercury 
Mercury is present in the environment in elemental, inorganic, and organic forms (Solan and 
Lindow 2014). Humans may be exposed to elemental forms though inhalation of mercury 
vapors from e.g. small-scale goldmining, and from dental amalgam fillings. The most 
common form of dietary mercury is methylmercury, which is the form of some relevance for 
this thesis. Human exposure occurs mainly through intake of fish and seafood, in which 
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methylmercury is bioaccumulated and biomagnified. The main effect of methylmercury is 
damage to the nervous system (Harada 1995), particularly the developing brain. Exposure to 
methylmercury during pregnancy has been associated with irreversible effects in children, 
such as motor and cognitive dysfunctions, even when there are no overt symptoms in the 
mother (Antunes Dos Santos et al. 2016).  
An antagonistic relationship between mercury and selenium was first observed in rats 
(Parizek and Ostadalova 1967), where co-administration of sodium selenite prevented the 
nephrotoxic effects of inorganic mercury. Co-exposure to selenium (often high doses) has 
also been shown to reduce the acute toxicity of both inorganic mercury and methylmercury, 
as well as to prolong the life expectancy, growth rate, and decrease the neurotoxicity in 
experimental studies (Cuvinaralar and Furness 1991). Several studies have found that 
selenium decreases the retention of mercury (both inorganic and organic) in kidneys, while 
others have found that selenium increases the methylmercury concentrations in e.g. the brain 
(Whanger 2001). Given these contrasting findings, it has been suggested that there might be 
different mechanisms involved in the interactions depending on the chemical forms of both 
elements (Cuvinaralar and Furness 1991). These mechanisms include i) redistribution of both 
elements between tissues, ii) competition for binding sites, iii) complex formation into inert, 
non-toxic conjugates, iv) conversion from toxic forms to less or non-toxic forms, and v) 
prevention of oxidative damage. Indeed, it has been reported in in vitro studies that mercury 
may inhibit both GPx (Franco et al. 2009; Hirota et al. 1980) and TrxR (Carvalho et al. 2008).  
However, there are few human studies that have assessed a potential protective effect of 
selenium on methylmercury toxicity. A recent epidemiological study from the Faroe Islands 
did not find evidence of an interaction between cord blood mercury (mainly methylmercury) 
and selenium when assessing children’s neurological function at 7 years (Choi et al. 2008). 
However, there was an indication of a stronger adverse mercury-related effect when assessing 
finger tapping at 7 years in the lowest group of cord blood selenium. In addition, the authors 
suggest that a protective effect of selenium was not detectable due to the high relative 
concentration of selenium to mercury (molar ratio), implying that children in the lowest 
selenium group were also protected. 
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3 AIMS 
The overall aim of the present thesis was to clarify the impact of early-life selenium status on 
child development. Specifically, this PhD thesis aimed to elucidate: 
 The influence of maternal selenium status during pregnancy on children’s cognitive 
abilities at 1.5 years of age (Paper I), 
 
 If hair is a useful biomarker for assessment of selenium status, as well as internal 
dose of other elements, in the studied children (Paper II), 
 
 Whether any effetcs of maternal selenium status during pregnancy on children’s 
cognitive abilities are still present when children are older, and whether children’s 
own selenium status is also of importance (Paper III), 
 
 Factors influencing selenium status and kinetics in children (Paper IV). 
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4 MATERIALS, METHODS, AND CONSIDERATIONS 
4.1 STUDY AREA AND PARTICIPANTS 
4.1.1 MINIMat 
The studies included in the present thesis are based on data from a mother-child cohort nested 
in a food and micronutrient supplementation trial established in Matlab, a rural area 53 km 
south-east of Dhaka, Bangladesh (Figure 6).  
In this area, the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 
provides health services via a central hospital and four health care facilities. In addition, 
icddr,b has been collecting information via a health and demographic surveillance system 
(HDSS) through monthly visits by experienced community health workers. Information such 
as pregnancies, births, deaths and migration has been registered over the past 60 years (Karar 
Zunaid Ahsan and Rahman 2009).  
The original study (MINIMat, the Maternal and Infant Nutrition Intervention, Matlab) was a 
food and micronutrient supplementation trial during pregnancy, implemented from October 
2001 to November 2003 (Persson et al. 2012). Eligibility criteria for enrollment were viable 
fetus, gestational age less than 14 weeks, no severe illness, and written consent for 
participation. In total, 4436 pregnant women were recruited and randomized into three 
supplementation groups [starting from gestational week (GW) 14]; either 30 or 60 mg iron 
and 400 µg folic acid (the latter WHO’s standard supplementation for pregnant women) or a 
Block C  
Block B 
Block A 
Block D  
Block A 
Figure 6. Map of Matlab, Bangladesh, including the health care facilities (sub-centers) and hospital. 
Adapted from (Nasreen et al. 2014). 
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multiple micronutrient capsule containing 30 mg iron and 400 µg folic acid together with 13 
additional micronutrients, including 65 µg of selenium in the form of sodium selenite. This 
daily supplement was combined with either early (GW9) or usual (GW20) start of food 
supplementation (Persson et al. 2012), resulting in six groups. The food supplementation 
consisted of 80 g of roasted rice powder, 40 g of roasted pulse powder, 20 g of molasses, and 
12 mL (6 g) of soybean oil, which provided a total of 608 kcal. The food supplementation 
was provided six days a week. Out of the 4436 pregnant women recruited to the trial, 845 
were lost-to follow up during pregnancy due to fetal loss (10%), out-migration from the study 
area (4%), or refusal to participate (3%). In total, there were 3625 live births, and 3267 were 
singletons with anthropometry measured at birth. 
Early in the study it was discovered that elevated exposure to arsenic through drinking water 
was common in this area, and therefore a longitudinal research project was initiated to 
evaluate potential developmental effects of arsenic and other environmental pollutants, 
mainly dietary toxicants (see e.g. Gardner et al. 2013; Kippler et al. 2012b; Vahter et al. 
2006). For exposure assessment in early pregnancy, we kept an aliquot of the urine sample 
collected for pregnancy testing. The present thesis is based on this nested cohort of pregnant 
women and their subsequently born children who have been followed-up for growth, immune 
function and toxicity markers, as well as developmental assessment until 10 years of age. 
4.2 DESIGN  
For the follow-up of child health in relation to toxic and essential elements, the children were 
divided in two groups (immune cohort and developmental cohort) in order to limit the study 
burden for each child. The studies in the present thesis (paper I-III) are based on both 
groups. For a brief overview of the studies, see Figure 7.  
Out of the 3267 single births in MINIMat, 2853 mother-child pairs with children born 
between May 2002 and December 2003 were invited to participate in the developmental 
follow-up when the children were 1.5 years, and 2112 agreed to participate (74%). The main 
reasons for loss to follow-up were being away from home on visits (n=351, 47%), refusal 
(n=185, 25%), death (n=89, 12%), moving out of the study area (n=52, 7%), disability (n=5, 
<1%) and illness at the time of testing (n=59, 8%; Hamadani et al. 2010b). Of the mothers 
recruited throughout 2002 (n=2119), 900 had donated blood samples in late pregnancy 
(GW30) that were analyzed in 2012-2013 for other purposes (Rahman et al. 2015). Reasons 
for missing blood samples were blood samples being used for other purposes and refusal. The 
overlap between these two groups (children born May 2002-December 2003 and women 
recruited throughout 2002) constituted the sample used in paper I (n=750). 
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At the developmental assessment at 5 years, 2260 of the children participated (79% of 
invited), and finally, children born between October 2002 and November 2003, who 
participated in the follow-ups at both 1.5 and 5 years (n=1885), and were alive and registered 
as residents in the study area, were invited to the follow-up at 10 years (n=1607). Out of these 
children, 1530 (95%) agreed to participate. We had available blood samples from GW14 for 
more women than we had from GW30, and after the findings in paper I, we chose to analyze 
and use the blood samples from GW14 to increase the sample size for paper III. In total, 
blood from GW14 was available from 1408 women, and this group of mother-child pairs 
constituted the sample for paper III.  
Paper II and IV were based on children in the immune cohort (Figure 7). Children born 
from June 2003-June 2004 were followed-up at 4.5 and 9 years for assessment of especially 
immunotoxic effects of arsenic, and these children donated blood, urine, and at 9 years also 
hair. There was an overlap between these two sub-cohorts consisting of children born 
Figure 7. Project overview for paper I-IV and the division of the MINIMat children into the two 
groups for assessment of either immune function (immune cohort, left) or cognitive development 
(developmental cohort, right). 
 
Developmental cohort Immune cohort 
Paper IV 
Paper I 
Paper III  
Women recruited to MINIMat  
(Nov 2001-Oct 2003) 
Blood collection at gestational 
week 14 and 30 
Children born into MINIMat 
Developmental assessment and urine 
collection at 5 and 10 years;  
Hair and water collection at 10 years 
 
Blood, DNA, urine, and 
hair collected at 9 years 
Developmental assessment 
at 1.5 years 
Blood and urine 
collected at 4.5 years 
Paper II Overlap between sub-cohorts  
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between June and December 2003, for whom all biological samples were collected (in the 
immune cohort), as well as water and hair samples (in the developmental cohort) at 10 years 
of age. These children, who participated in both sub-cohorts, constituted the sample used in 
paper II (n=207).  
Blood and/or urine samples from 511 9-year-old children were available for analyses of toxic 
metals and essential elements (immune cohort). Out of these children, 395 had enough high-
quality DNA for genotyping, and all covariates available. Thus, these 395 children 
constituted the sample used for paper IV, which also included 259 children from the immune 
cohort with available samples (erythrocytes and urine) from 4.5 years for comparison (243 of 
which overlapped with the 395). 
4.3 SAMPLING AND DATA COLLECTION 
4.3.1 Biomarkers of exposure and status  
As discussed under section 2.1.4, there are great uncertainties regarding suitable markers of 
selenium status, especially in children. Therefore, we have put much emphasis on the 
evaluation of selenium concentrations in the different biological media available in the study 
cohorts and factors influencing these concentrations. This felt important in order to evaluate 
the impact of selenium status on child development.  
Maternal selenium status was evaluated through concentrations in erythrocytes (papers I and 
III), and concentrations in urine were also measured. For a sub-sample, we also had plasma 
selenium for comparison (n=98). For children in the developmental cohort, we measured 
selenium in urine at 5 and 10 years, and also in hair at 10 year (paper III). At 4.5 and 9 
years, selenium was measured in erythrocytes and urine, and at 9 years also in plasma and 
hair (papers II and IV). We calculated the ratio between plasma/urinary selenium at 9 years 
as an estimation of selenium retention, where a higher ratio indicates higher retention. We 
also calculated the ratio between erythrocyte/plasma selenium to assess distributional changes 
between the blood compartments in relation to the assessed factors (paper IV). 
Community health workers visited Matlab families monthly on a routine basis, and women 
who reported that they had missed their last menstruation were tested for pregnancy by urine 
test. In case of positive results, about 20 mL of the urine collected in plastic urine collection 
cups was transferred and kept in a 24 mL plastic, acid-washed, bottle for long-term storage. 
This sample was collected at GW8 on average. During the antenatal visits at GW14, 19, and 
30, and at the follow-ups of the children at 4.5 and 9 years (immune cohort), or 5 and 10 
years (developmental cohort), spot urine samples were collected at the health care facilities. 
All samples were refrigerated until they were frozen at -70oC at the Matlab hospital.  
During pregnancy, blood samples were collected in 5.5 mL Li-heparin tubes (Sarstedt, 
Nümbrecht, Germany) when the women visited the health care facilities at approximately 
GW14 and 30. From the children that participated in the immune cohort, venous blood 
samples were collected in Na-heparin tubes (Vacuette, Greiner Bio-One International AG, 
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Kremsmünster, Austria) at 4.5 and 9 years of age. Samples were transported to the Matlab 
hospital and centrifuged for separation of plasma and erythrocytes, and the fractions were 
stored at -70 and -20oC, respectively. The sampling material used for both blood and urine 
collection had been tested to be trace element free. 
For the follow-ups at 9 and 10 years, the community health workers were trained (orally and 
by detailed written instructions) to collect hair samples at the local health care facilities. Hair 
samples from the occipital part of the children’s heads were cut with 18/8 stainless steel 
scissors, as close to the scalp as possible. The sample was tied together with a nylon thread 
(less contaminants compared to cotton) at the end closest to the scalp, and placed in high 
quality paper envelopes to avoid static electricity.  
At the follow-up at 9 years, children participating in the immune cohort were sampled before 
and after a vaccination, with 21 days in between (Raqib et al. 2017). Because the samples 
were also used for other purposes, the samples included in Paper IV were from different time 
points. For plasma and urine, we had samples collected before vaccination, while the 
erythrocytes were from the second sampling. For hair, the samples used in paper II were 
those collected in the developmental cohort (9.5-10 years of age, at the time of water 
collection), and these samples were approximately half of those included in paper IV. The 
remaining hair samples used in paper IV were collected in the immune cohort, prior to the 
vaccination (9 years).   
All samples were transported frozen and analyzed at Karolinska Institutet, Sweden, except for 
hair samples which were kept and transported at room temperature.   
4.3.2 Covariates 
Information on maternal characteristics was obtained either at enrollment into MINIMat 
[maternal age, BMI (kg/m2), education, parity] or from HDSS (e.g. assets and housing 
conditions). Family socioeconomic status (SES) was derived using a wealth index based on 
factors such as lands, assets, housing structure, and household sanitation (Gwatkin et al. 
2000). This information was updated at the follow-ups of the children, and so was the 
information regarding maternal and paternal education (years of formal schooling). The SES 
score was used both as a continuous variable (papers I-III), but was also divided into 
quintiles for ease of interpretation (paper IV). Maternal non-verbal IQ was assessed at the 5-
year follow-up using the Raven’s Coloured and Progressive Matrices. In addition, the quality 
and quantity of children’s stimulation at home was assessed at both 1.5, 5, and 10 years using 
a modified version of Home Observation for Measurement of the Environment (HOME; 
Bradley et al. 2003; Caldwell 1967), which is based on questions regarding e.g. 
responsibility, parent-child interactions, learning materials and opportunities, family 
integration, and physical environment.  
Children’s birth anthropometry was measured according to standard procedure by the 
attending nurse or by a trained paramedic for those with home delivery (Persson et al. 2012). 
Birth weight was measured using an electronic beam scale precise to 10 g. Children’s height 
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was also measured at each follow-up using either a locally manufactured wooden stadiometer 
(precise to 0.1 cm; used for developmental cohort) or a free standing stadiometer (Seca 214, 
Leicester Height Measure; Seca GmbH & Co., Hamburg, Germany; used for immune 
cohort). Children’s weight was measured using a digital scale (TANITA HD – 318, Tanita 
Corporation, Japan) precise to 0.1 kg at all follow-ups. In addition to their height and weight, 
BMI was calculated, as well as standardized scores (HAZ, height-for-age z-score; WAZ, 
weight-for-age z-score; BAZ, BMI-for-age z-score) using the WHO growth references 
(WHO 2010). Underweight was defined as WAZ<−2 (lower than two SDs from the median 
weight-for-age of the reference population defined by WHO) and stunting was defined as 
HAZ<−2. Children’s hemoglobin (Hb) was measured at 4.5, 9, and 10 years in peripheral 
blood (finger prick), using a HemoCue photometer (Hemocue AB, Ängelholm, Sweden). 
At the follow-up at 5 years, information on the type of school [none, primary, Madrasa 
(Islamic), kindergarten, Maktab or non-formal] was collected, and this information was 
updated at the follow-up at 10 years [none, public primary school, Madrasa school, NGO 
(nonprofit private) school, and English medium (private school)]. In addition, information on 
children’s years of formal education was collected at the 10-year follow-up. Season of 
sampling was defined as pre-monsoon (January-May), monsoon (June-September), or post-
monsoon (October-December).  
At 9 years, children were genotyped for INMT using allelic discrimination for SNPs 
rs6970396, rs4720015, and rs1061644. Samples were analyzed on a LightCycler 480 II with 
software SW 1.5.1 (Roche, Switzerland) using TaqMan probes (Assay ID C__29402264_10, 
C__25755281_30, and C__2641592_10; Applied Biosystems). No SNPs deviated from 
Hardy-Weinberg equilibrium, which was evaluated using chi-square analysis [criterion for 
deviations χ2>3.84 (p<0.05)]. Data is presented only for rs6970396 (paper IV), as the three 
SNPs were in complete linkage disequilibrium (Kuehnelt et al. 2015).  
Finally, arsenic, cadmium, lead, manganese, and zinc were analyzed in erythrocytes and 
urine, and mercury and arsenic were analyzed also in hair, and arsenic also in plasma, as 
described in section 4.4.1.  
4.4 ANALYTICAL METHODS 
4.4.1 ICP-MS 
We measured the concentrations of selenium, as well as multiple, other elements, in all 
samples using inductively coupled plasma mass spectrometry (ICP-MS; Agilent 7700x, 
Agilent Technologies, Tokyo, Japan) equipped with octopole reaction system 
collision/reaction cell technology, at the Unit of Metals and Health, Institute of 
Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. With this method, 
aerosol droplets of liquid samples are introduced into a torch with ionized argon gas, in which 
molecules are atomized and ionized (positively). The ions are then directed into the mass 
spectrometer, where they are separated based on their mass-to-charge ratio, and translated to 
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an electric signal that can be measured and quantified based on calibration standards. This 
technique provides a lower detection limit and requires a smaller sample volume, offers 
higher throughput, and is applicable to more elements compared to other techniques such as 
atomic absorption (Nageswara Rao and Talluri 2007). Selenium (and calcium) was analyzed 
with the collision/reaction cell in hydrogen gas mode, while other elements were analyzed in 
helium mode (magnesium, manganese, iron, cobalt, copper, zinc, arsenic, molybdenum, and 
cadmium) or in no gas mode (lead, mercury, and iodine) to minimize spectral interferences.   
4.4.2 Sample preparation  
4.4.2.1 Urine 
Prior to analyses, urine samples were diluted 1:10 in 1% nitric acid (65% w/w, Scharlau 
Trace Analysis Grade, Scharlab S.L., Sentmenat, Spain). Concentrations in urine were 
adjusted to the average specific gravity (1.012) measured by a digital refractometer (RD 712 
Clinical Refractometer, EUROMEX microscopes, Holland) to compensate for variations in 
dilution (Nermell et al. 2008). This method provides concentrations of total selenium in urine, 
which was also measured for cadmium. For arsenic, however, total urinary concentrations 
include also organic species (considered less toxic than the inorganic species). Therefore, 
urinary arsenic was speciated using high-performance liquid chromatography on-line 
coupling with hydride generation ICP-MS (HPLC-HG-ICP-MS), as described before 
(Gardner et al. 2011). The sum of the measured arsenic species [iAs (III), iAs (V), MMA (V), 
and DMA (V)] was then calculated and used as a measure of exposure to iAs. For iodine, 
samples were diluted 1:10 with 0.1% NH4OH and analyzed in no gas mode, as described in 
detail before (Rydbeck et al. 2014). 
4.4.2.2 Blood fractions 
For erythrocyte fractions from GW14 analyzed in 2007, as well as all those collected at 
GW30 (analyzed in 2012-2013), sample preparation included acid digestion which has been 
described in detail previously (Kippler et al. 2009). In short, about 0.5 g of sample was 
digested in quartz tubes in 2 mL concentrated HNO3 (65% suprapur, Merck, Darmstadt, 
Germany) and 3 mL deionized water under high pressure (40 bar) and temperature (250oC) 
for 30 minutes in a Milestone ultraCLAVE II microwave digestion system (EMLS, 
Leutkirch, Germany). Digested solutions were then diluted to a final acid concentration of 
20%. The remaining blood samples (erythrocyte fractions from GW14, 4.5, and 9 years, and 
plasma fraction from 9 years) were diluted with an alkaline solution, which after careful 
testing had shown comparable results with the digestion method and even lower LOD for 
selenium (Lu et al. 2015). About 0.2 mL of sample was diluted 1:25 in a solution containing 
2% (wt:vol)1-butanol, 0.05% (wt:vol) EDTA, 0.05% (wt:vol) Triton X-100, 1% (wt:vol) 
NH4OH and 20 µg/L internal standard (Sigma-Aldrich, Schnelldorf, Germany), after which 
the samples where vortex mixed, sonicated for 5 minutes, and centrifuged at 1000 rpm for 2 
minutes [MSE centrifuge, Super Minor, MSE (UK) Ltd, London, England]. We also adjusted 
the erythrocyte concentrations for Hb, however the adjusted and unadjusted values were 
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highly correlated (paper I). Plasma samples (used in paper IV) were also diluted in the 
alkaline solution described above, although the dilution factor was 1:60 due to very small 
sample volume remaining. To assess the impact of such a high dilution factor, we first 
performed a pilot study to assess whether this had any impact on the quantifiability. We 
measured selenium and arsenic in plasma diluted 1:25, 1:50, and 1:60 in 5 different samples 
(Figure 8).  
The concentrations differed marginally, and there were no difficulties quantifying the 
selenium concentration for any dilution factor (signal/noise>3 for all, indicating that the 
sample signal is well above the signal of the blanks). For arsenic, some samples had a 
signal/noise ratio<3, suggesting that the lowest concentrations were less precise when using 
higher dilution factors. However, given the similar results regardless of dilution factor for 
each respective sample, we did not consider this a major issue. Also, there was no obvious 
trend for the arsenic concentrations with increasing dilution factor.   
In paper IV, the element concentrations in  the blood fractions were adjusted to the average 
density of plasma (1.026) and erythrocytes (1.096; Lentner 1981) to convert concentrations 
from µg/kg to µg/L for comparability with other studies.  
4.4.2.3 Hair 
Prior to analysis of hair samples, bundles of about 2 cm of hair (about 50 mg; closest to the 
scalp) were washed in 50 mL 2% Triton X-100 for 1 hour, rinsed 10 times in deionized 
water, and dried for 24 hours at room temperature. For samples from children with hair 
shorter than 2 cm, the whole sample was used (minimum 10 mg). The samples were weighed 
on a calibrated (internal and external) analytical balance (Precisa 202A, Dietikon, 
Switzerland) close to an alfa source (Staticmaster model 2U500, NRD, US) to avoid static 
electricity as this may cause large errors in the obtained weight.  
In a pilot study, we first attempted to digest the hair samples in concentrated HNO3 in room 
temperature overnight, or until the whole sample had dissolved. We then analyzed the 
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Figure 8. Plasma concentrations of selenium and arsenic in 5 different samples (each color 
represents one sample) diluted either 1:25, 1:50, or 1:60.  
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solution after diluting it with deionized water to an acid concentration of 20%. Duplicates of 
the samples were acid digested as described above for erythrocytes, and the obtained 
concentrations were compared. However, the concentrations obtained after the alternative 
method (overnight digestion) did not correspond very well with those from the standard acid 
digestion method (Table 3), and thus, we chose to digest all samples according to the standard 
method. For mercury analyses, we diluted the digested hair samples to 20% HNO3, and also 
stabilized with 2% concentrated HCl (Emsure®, ACS, ISO, Reag. Ph. Eur., Merck Darmstadt 
Germany; Gustin et al. 2017).  
Table 3. Concentrations of selenium and arsenic (µg/kg) in hair digested by two different methods. 
 
4.4.3 Analytical performance 
For test of accuracy as well as precision, all analyses described above included commercial 
reference materials for whole blood, plasma, urine, or hair. For hair, we also included an in-
house sample from multiple residents of the Faroe Islands in each analysis. Usually, the 
reference samples were included in the beginning, middle and end of each analytical run, 
together with one standard (in the middle of the standard curve). The obtained results were 
generally in good agreement with the recommended values, as shown in the supplemental 
material of paper I-IV, indicating accurate results. In addition, the variation in the obtained 
concentrations between all the runs was low, showing high precision. A summary of all 
reference materials analyzed for selenium together with samples included in any of the 
studies of the present thesis [except for those already described in (Kippler et al. 2009)] are 
presented in Table 4.  
 
 
Ultraclave digestion Overnight digestion Ratio 
Selenium 
   Sample 1 463 649 0.71 
Sample 2 451 708 0.64 
Sample 3 492 669 0.74 
Sample 4 347 515 0.67 
Arsenic    
Sample 1 35 47 0.74 
Sample 2 37 53 0.70 
Sample 3 11 15 0.73 
Sample 4 32 44 0.80 
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Table 4. Recommended and obtained concentrations of selenium (µg/L or µg/kg) for all reference 
materials included in any of the analyses in paper I-IV, as well as the limit of detection (LOD; 3xSD 
of blanks) and coefficient of variation (CV).  
 
The limit of detection (LOD) was calculated as 3xSD of the blanks of each analytical run, and 
no sample had a selenium concentration below this value for any of the biomarkers used in 
any of the papers. A few samples had concentrations below the LOD for the other elements 
analyzed (plasma arsenic in particular, n=6), and we either replaced these with LOD/√2 (if 
negative, concentrations very close to the blank values), or kept them as measured (if 
positive).  
The two different methods of sample treatment used for erythrocyte analyses were strongly 
correlated (Lu et al. 2015), although the concentrations from the acid digested samples were 
consistently about 10% higher than those following alkali dilution. Thus, we adjusted the 
sample concentrations measured using the acidic method by multiplying them with 0.9 
(paper III).  
 
Recommended 
value 
Obtained 
value n CV LOD 
Erythrocytes 
     Seronorm Whole Blood 1103129 112 ± 23 119 ± 6.9 137 5.8% 0.025 
Seronorm Whole Blood 1103128 59 ± 12 57 ± 3.2 135 5.7% 0.025 
Seronorm Whole Blood 1406263 57 ± 11 59 ± 1.3 17 2.2% 0.025 
Seronorm Whole Blood 1406264 153 ± 30 162 ± 3.6 18 2.3% 0.025 
Plasma 
    
 
Seronorm serum Mi0196 83 ± 6 71 ± 5.2 18 7.4% 0.11 
Medisafe serum 28341 50 ± 9 50 ± 3.2 18 6.4% 0.11 
Urine 
    
 
Seronorm urine NO2525 67 ± 7.1 73 ± 4.6 76 6.3% 0.014 
Seronorm urine OK 4636 22 ± 2.8 24 ± 2.2 76 9.2% 0.014 
NIST2670aH 230 ± 8.3 190 ± 24 36 13% 0.014 
NIST2670aL 8 ± 3 7.4 ± 1.1 23 15% 0.014 
Seronorm urine 1011645 70 ± 14 74 ± 3.3 54 4.5% 0.014 
Seronorm urine 1011644 14 ± 2.8 15 ± 0.51 55 3.4% 0.014 
Hair 
    
 
NCSZC 81002b 590 ± 40 633 ± 96 30 15% 0.020 
IAEA-086 1000 ± 200 1080 ± 80 18 7.4% 0.020 
Faroe hair - 1680 ± 181 112 11% 0.020 
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To assess whether storage time prior to analysis has any impact on the selenium 
concentrations, we reanalyzed 20 erythrocyte samples from the children included in paper 
IV after storing them at -80oC for almost four years. The results showed good agreement 
(Figure 9). 
4.5 OUTCOMES 
Children were followed-up at 1.5, 5, and 10 years for developmental assessment 
(developmental cohort), as well as at 4.5 and 9 years for biomarker evaluation (immune 
cohort, mentioned under 4.3.1).  
4.5.1 Cognitive abilities 
At 1.5 years (paper I), child development (mental development and psychomotor 
development) was assessed using a revised version of the Bayley Scales of Infant 
Development (BSID-II; Saha et al. 2010). The tests were conducted by psychologists at the 
local health care facilities, and involved tasks such as problem solving and vision fixation. 
These procedures were videotaped and scored, and the scores from each test were converted 
into a total z-score. The test was modified and adapted to the Bangladeshi culture based on 
piloting in rural areas. The changes were limited to the minimum required and included a few 
pictures used to assess the mental development. In addition, children’s language development 
was assessed using an inventory specially developed for Bangladesh (Hamadani et al. 2010a). 
This inventory was based on the principles of the MacArthur Communicative Development 
Inventory (Fenson et al. 2002), in which the score is constructed from children’s recognition 
and usage of words and actions, according to the mother’s report.  
Figure 9. Erythrocyte selenium concentrations (µg/kg) in 20 samples 
reanalyzed after almost four years in -80oC. 
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At 5 years (paper III), children’s cognitive function was assessed using the third edition of 
the Wechsler Pre-school and Primary Scale of Intelligence (WPPSI) at the nearest health care 
facility (Wechsler 2002). WPPSI was culturally adapted and modified for use in Bangladeshi 
children (Hamadani et al. 2011). Seven subtests of WPPSI were used; information, 
vocabulary and comprehension were summed to form the verbal score, while block design, 
matrix reasoning and picture completion formed the performance score. Finally, processing 
speed as well as the verbal and performance score were summed to generate the children’s 
full developmental score.  
At 10 years (paper III), the Wechsler Intelligence Scale for Children, 4th edition (WISC-IV) 
was used. This was also culturally adapted to fit the present population with slight changes in 
the questions and translation to Bengali. The test generates four scales; verbal comprehension 
(based on vocabulary, information and comprehension), perceptual reasoning (based on block 
design, picture concept and matrix reasoning), working memory (based on digit span and 
arithmetic’s), and processing speed (based on coding and symbol search). In addition, the full 
developmental score was calculated (sum of sub-scores), which represents the child’s general 
intellectual ability. The raw scores of each test (both at 5 and 10 years) were used to exclude 
bias due to comparison with other culture norms. 
4.6 ETHICAL CONSIDERATIONS 
All studies have been ethically approved by the Research and Ethical Review Committees of 
icddr, b (Bangladesh), and the Regional Ethical Review Board of Karolinska Institutet, 
Stockholm, Sweden.  
Written and oral consent was obtained from the mothers before enrollment into the MINIMat 
trial. In addition, parents or guardians gave their written consent prior to the children’s 
participation at each follow-up. Women and children were informed about their option to 
refrain from the study at any time point without affecting their access to routine health 
services.  
There are no risks with donating urine samples. For blood, there is a small risk for bleeding, 
bruising, or a local inflammation. However, sterile needles were used (eliminating the risk of 
spreading any contagious diseases), and blood was drawn by experienced staff to minimize 
discomfort. In order to lower the study burden for each child, the cohort was divided in two 
parts, one with focus on toxic mechanisms and one focusing on effects on child development. 
All of the results concerning measured exposures and associations with the various outcomes 
have been reported to responsible PIs and other involved researchers at icddr,b. Because most 
of the analyses and evaluations were performed long after the follow-ups, it was not possible 
to report the results back to the families. However, in case of abnormal results, this was 
communicated to the responsible PI at icddr,b. The initially measured arsenic concentrations 
in the well water, usually one per family, were communicated by painting the pumps read 
[high arsenic, >50 µg/L (national cut-off)] or green (low arsenic, <50 µg/L). Also, in 
collaboration with BRAC, a non-governmental organization, the public was informed about 
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the health risks with arsenic in the drinking water in each village and recommendations were 
given for pregnant women and children, in particular, to collect drinking water from a green-
painted well. Later, many families had deeper wells installed to decrease the arsenic 
concentrations in the drinking water, and we assessed the effectiveness of this mitigation 
effort by analyzing the arsenic concentrations in water and urine (Kippler et al. 2016b).  
4.7 STATISTICAL ANALYSES 
For a more detailed description of all statistical methods used, the reader is referred to each 
individual study (paper I-IV). 
All statistical analyses were performed using Stata/IC (version12; StataCorp). Throughout 
paper I-IV we used complete subject analyses, i.e. participants with missing covariate data 
were excluded, assuming these data were missing at random. Bivariate associations between 
continuous variables were assessed using Spearman’s correlation coefficient, while those 
between continuous and categorical variables were assessed using Kruskal-Wallis, Mann-
Whitney U-test, chi-squared, or Fisher’s exact test. Scatter plots with Lowess moving-
average lines were used to visually examine all studied associations. For paper II and IV, we 
log2-transformed the concentrations of multiple elements due to skewness, which also 
simplified the visualization of any associations with these elements.  
All associations evaluated in the present thesis were assessed using multivariable-adjusted 
regression analyses. Linear regression was applied when associations appeared linear, while 
linear spline regression with one or two knots was used to evaluate indicated non-linear 
relationships. For comparison of goodness of fit for linear vs spline models, we used the F-
test, and chose the model with significantly higher R2. For regression diagnostics, we used 
fitted vs residual plots and q-q plots. The results are presented as B-coefficients (non-
standardized) and 95% confidence intervals (CI).  
The regression models were adjusted for variables that are known to affect the outcomes, or 
that correlated with both selenium status and any of the outcomes in each respective study. 
We also applied backwards elimination starting with the variable with the highest p-value, 
and dropped variables if the R2 was significantly improved after exclusion. For highly 
correlated variables (rS>0.60), we included the variable that resulted in the highest R2. 
We performed various sensitivity analyses to assess potential mediation, and to determine the 
effect of extreme values on the overall results. In addition, we stratified on population groups 
(e.g. by gender or SES) to assess potential effect-modification, and included multiplicative 
interaction terms in the non-stratified models. Differences between estimates were tested 
using the Wald test. A p-value <0.05 was considered statistically significant, except for 
interaction terms, for which a p-value<0.10 was considered significant.
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5 RESULTS AND DISCUSSION 
In order to increase our understanding of the importance of selenium for early-life 
development, we initiated the studies described below, which are based on an ongoing 
mother-child cohort in rural Bangladesh, enabling prospective evaluation of selenium status 
and children’s cognitive development. Given the lack of knowledge on the impact of 
adequate selenium status for early-life development, the most important findings of the 
present thesis are the positive associations between selenium status and children’s cognitive 
abilities. The main results from each of the papers (I-IV) are presented below, as well as 
some unpublished data. For more details, please see each respective paper.  
5.1 SELENIUM STATUS AND COGNITIVE FUNCTION 
5.1.1 Maternal selenium status and children’s cognition 
In the first study (paper I), we evaluated the importance of prenatal selenium for the 
cognitive abilities in early childhood. We found a positive association between maternal 
erythrocyte selenium, measured in the third trimester (GW30; range 0.19-0.87 µg/g Hb; 
corresponding to 78-335 µg/L), and all measures of children’s cognitive function, but 
psychomotor development and language comprehension in particular, assessed at 1.5 years 
(n=729; Figure 10). For mental development index and language expression, we found no 
significant associations, although the estimates were in general positive. The regression 
analyses were adjusted for age at testing, gender, gestational age at birth, HOME, weight-for-
height z-score, birth weight, maternal age, family SES and maternal BMI. In two additional 
models, we further adjusted for other essential (iodine, manganese, and zinc) and toxic 
(arsenic, cadmium, and lead) elements.  
In the stratified analysis, the association with psychomotor development appeared stronger 
for the girls; the estimate was 2.6 times higher than that for the boys. For language 
comprehension, on the other hand, the associations appeared slightly stronger among boys 
(1.7 times higher estimate). However, after now repeating this analyses and including an 
interaction term (child gender × erythrocyte selenium), we find no significant interaction for 
any of the outcomes (p>0.25 for all), implying that the estimates for girls and boys were not 
statistically different. This may suggest that the differences in estimates were random, 
although a larger sample size would have resulted in more narrow confidence intervals, 
which would have clarified this. 
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For language comprehension, there was an indication of a non-linear relationship, why we 
used linear spline regression with two knots for the evaluation. We have also repeated the 
analyses using linear regression (no spline knots) and found that the predictive value of the 
model is actually marginally higher than that for the linear spline model (R2=0.353 vs. 
R2=0.351). This model also revealed that the association between maternal erythrocyte 
selenium and children’s language comprehension remains significant (with the same effect 
estimates) regardless of adjustment for other essential elements (corresponding model 3; 
B=3.1, 95% CI: 0.16, 6.0, p=0.039) or toxic elements (corresponding model 4; B=3.5, 95% 
CI: 0.84, 6.1, p=0.010). We now also included an interaction term between maternal 
erythrocyte selenium and supplementation group, and additionally adjusted all analyses for 
supplementation group. We found no difference in the estimates (<7% difference between 
adjusted and non-adjusted models) for erythrocyte selenium at GW30 (further discussed 
under 5.2), and no interaction between selenium concentration and supplementation group.  
At the follow-ups at 5 and 10 years, we found that the positive associations between maternal 
selenium status during pregnancy and children’s cognitive abilities were still present (paper 
III). The associations were less precise at the 5 year follow-up compared to that at 10 years. 
It is well established that the older a child is at the time of cognitive testing, the better is the 
prediction of later life cognitive function. In general, stability improves after 6 years of age 
Figure 10. Correlations [crude lowess line (dashed) and adjusted lowess line (solid)] between 
erythrocyte selenium (µg/g Hb) at gestational week 30 and mental development index (A), psychomotor 
development index (B), language comprehension (C) and  language expression (D). The adjusted lowess 
line is adjusted for age at testing, gender, gestational age at birth, HOME, weight-for-height z-score, 
birth weight, maternal age, family SES and maternal BMI. 
rS=0.049, p=0.19 rS=0.14, p<0.001 
rS=0.15, p<0.001 rS=0.095, p=0.011 
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(Berk 2013), which could explain why the associations between maternal selenium status 
during pregnancy and children’s cognitive abilities assessed at 5 years were more imprecise 
than those assessed at 10 years. Throughout all follow-ups, we generally found stronger 
estimates for girls compared to boys. However, at 5 and 10 years, the differences were small 
and not significant. Consequently, the data indicates that adequate early-life selenium status is 
important for cognitive development in both girls and boys. However, in paper IV (discussed 
further in section 5.3), we found that the selenium retention appeared to be higher in girls 
than in boys, although we could not find any apparent reason for this. Differences in selenium 
metabolism could impact the health effects of selenium, and thus, potential gender difference 
should be assessed further in future studies. 
We found no significant differences in selenium-related estimates for the outcomes at 10 
years between children born preterm/term, that were stunted/normal height, or that had 
low/high SES (p>0.18 for all interaction terms for full score 10 years), implying that 
selenium is important independent of these factors. 
At 1.5 years, the increase in psychomotor development and language comprehension 
comparing the 5th to the 95th percentile of maternal erythrocyte selenium corresponded to 
~0.5 and 0.3 SD of the respective outcomes. At the follow-up at 5 years, the corresponding 
estimate for full developmental score was ~0.2 SD, and at 10 years ~0.3 SD. Taken together, 
the associations between prenatal selenium status and children’s cognitive abilities appear 
robust over time and independent of other factors.   
Since paper I was published (2015), other prospective studies have reported similar findings, 
but also contradictory results (Table 5). A large study performed in the U.S. found no 
association between maternal erythrocyte selenium at GW30 and child cognitive abilities at 
7.7 years, however, the selenium concentrations were generally quite high (Oken et al. 2016). 
Indeed, the studies reporting a positive association between maternal/cord selenium 
concentrations and child cognition/neurodevelopment have all included rather low 
concentrations (Kippler et al. 2016a; Polanska et al. 2016; Snoj Tratnik et al. 2017; Varsi et 
al. 2017), while those reporting inverse associations have reported higher concentrations 
(Boucher et al. 2014; Oken et al. 2016), and those around sufficient concentrations have 
indicated non-linear associations (Amoros et al. 2018a; Amoros et al. 2018b). This would 
suggest that the association is in fact non-linear, although the turning point is yet to be 
confirmed.   
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Table 5. Summary of studies on prenatal selenium status and children's cognitive abilities/neurodevelopment. 
Country Age Selenium assessment n Results Comments Reference 
Bangladesh 1.5 years Maternal erythrocytes: 
median 0.46 µg/g Hb 
606-713 + 
/ 
Positive associations between erythrocyte selenium 
(GW30), psychomotor development and language 
comprehension (significant), and mental development 
and language expression (non-significant) at 1.5 years.  
Strongest association in girls. Indicated non-
linear association for language comprehension. 
Paper I 
Bangladesh 5-10 years Maternal erythrocytes: 
median 0.45 µg/g Hb 
1260-1408 + Positive associations between erythrocyte selenium 
(GW14) and cognitive outcomes both at 5 and 10 years. 
Associations more clear for outcomes assessed 
at 10 years. 
Paper III 
Canada 6.5-11 
months 
Maternal plasma:  
mean 296.4 µg/L  
94 / No correlation between cord blood selenium and 
cognitive function. 
Analyses not adjusted for any confounders. 
Extremely high selenium concentrations. 
Boucher  
et al. 2014 
China 3 days Cord serum:  
mean  63.1 µg/L 
927 + Positive association between NBNA score and cord 
serum selenium up to 100 µg/L. 
Potential inverse association above 100 µg/L 
(n=80; inverted U-shape). 
Yang  
et al. 2013 
Greece 4 years Maternal urinary 
selenium: mean 23 µg/L 
575 + Positive associations with children’s general cognitive 
score. 
Borderline significance. Kippler et 
al. 2016 
Norway 6 months Maternal serum:  
mean 72 µg/L 
105 +
/  
Positive association between maternal serum selenium 
at GW18 and children’s ASQ total, problem solving, 
and fine motor scores.  
No association with other sub-scores and not 
with serum Se measured at GW28 or GW36.  
Varsi et al. 
2017 
Poland 1-2 years Maternal serum 1st 
trimester: 
mean 48.3 µg/L 
410 + Positive associations between plasma selenium (first 
trimester) and children's psychomotor abilities within 
the first 2 years of life. 
No measurements of maternal IQ, home 
environment, or other essential or toxic 
elements. 
Polanska  
et al. 2016 
  
Slovenia 
and Croatia 
1.5 years Cord blood serum: 
geometric mean 40.1 
µg/kg 
280 +
/ 
Borderline significant association with language 
composite score. Associations with other scores not 
reported. 
Association with selenium not primary 
outcome: reported estimate from adjusted Hg-
model. Potential influence of ApoE genotype.  
Snoj 
Tratnik  
et al. 2017 
Spain 1 year Maternal serum around 
GW13: mean 79.7 µg/L 
651 or 349 /  
- 
Non-linear model showed best fit. Inverse association 
with mental development indicated above 86 µg/L. 
Suggested different shapes depending on 
INMT genotype. 
Amoros 
et al. 2017 
Spain 5 years Maternal serum around 
GW13 : mean 79.9 µg/L 
490 +
/ 
- 
Non-linear model showed best fit with verbal and global 
memory scales, break point at 84 µg/L. 
Effect modification by breast feeding 
suggested. 
Amoros et 
al. 2018 
Sweden 5-17 years Cord serum:  
mean 48 µg/L; maternal 
serum: mean 72 µg/L 
180 cases, 
191 
controls  
- Increased odds of having ADHD with high selenium 
concentrations. 
Authors have no explanation for their results 
and suggest chance finding. 
Ode et al. 
2015  
U.S. 7.7 years Maternal erythrocytes: 
mean 206 µg/L 
872 / No association between maternal erythrocyte selenium 
at GW30 and child verbal or non-verbal intelligence, 
visual motor function, or visual memory. 
High selenium concentrations. Oken 
et al. 2016 
+ positive association, - inverse association, / no association. ADHD, Attention Deficit Hyperactivity Disorder; ASQ, Attachment Style Questionnaire; GW, gestational week; Hb, 
hemoglobin; INMT, indolethylamine N-methyltransferase; IQ, Intelligence quotient; NBNA, Neonatal Behavioral Assessment Scale. 
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5.1.2 Children’s selenium status and cognition 
5.1.2.1 Positive associations 
In paper III we found that also the children’s selenium status during childhood was 
associated with their cognitive abilities (Figure 11). Because of the lack of blood samples 
from the children in the developmental cohort, we assessed the status based on concentrations 
in urine and hair. The suitability of these biomarkers of selenium status is discussed in the 
following sections (5.3.1 and 5.3.2). The strength of the associations were similar at 5 and 10 
years when using urinary selenium, but were stronger when using hair selenium, the more 
long-term marker (10 years). In addition to the cross-sectional analyses, we also found an 
association between urinary selenium at 5 years and the full developmental score at 10 years. 
For an increase from the 5th to the 95th percentile in hair selenium, the corresponding increase 
in full developmental score at 10 years was about 0.2 SD, i.e. similar to the effect estimate for 
maternal selenium status in pregnancy. We now also included selenium in both hair (10 
years) and erythrocytes (GW14) in the analyses, and found that the associations with full 
developmental score persisted for both time point with similar effect estimates to those from 
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Figure 11. Scatter plots with smoothed lowess lines for childhood selenium (Se) and full 
developmental score (raw score) at 5 and 10 years. The vertical lines represent the turning point used 
for the knot in the linear spline regression analyses (34 µg/L for urinary selenium at 5 and 10 years and 
665 µg/kg for hair selenium at 10 years). 
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the separate models. Indeed, this supports the interpretation that adequate selenium status is 
of importance for brain development throughout childhood. Similar to the analyses including 
prenatal selenium, we found no evidence of effect modification for the association with hair 
selenium by gestational age at birth, SES, growth (HAZ), or gender (p>0.31 for all interaction 
terms for full score 10 years). Given the wide variations in these variables in the present 
cohort, the results indicate that the associations between selenium status and child cognitive 
development may be applicable also to other populations (further discussed under section 
5.4.4). 
For comparison with the present results, we have reviewed the few available studies that have 
assessed the impact of childhood selenium status on cognitive abilities, but also on motor 
function, with varying results (Table 6). Unfortunately, several of the studies included in 
Table 6 did not have selenium as the primary exposure, and have not assessed the relationship 
thoroughly, but merely through Spearman/Pearson correlations with the outcomes (Bumoko 
et al. 2015; Gashu et al. 2016; Gassio et al. 2008; Sun et al. 2015). Also, the studies are 
generally small. A study from Brazil found a positive association between plasma selenium 
and motor function, even though the mean plasma concentration was as high as 163 µg/L 
(Lemire et al. 2011). However, this study included participants between 15-87 years of age, 
and the requirement for selenium might be higher for older individuals, which could be 
driving the positive association. Another study from Bangladesh presented a positive 
association between selenium status and children’s motor function at 9.6 years of age in one 
of the sub-tests (Parvez et al. 2011), and the concentrations were similar (mean 105 µg/L in 
whole blood) to those estimated in the present population [119 μg/L (paper IV), assuming a 
hematocrit (%) of 3xHb (g/dL; Dosoo et al. 2014)]. 
The effect estimates from paper I and III may seem small, and on an individual level such 
changes in cognitive abilities (corresponding to 3-5 IQ-points for a change from the 5th to the 
95th percentile) will not be of high clinical relevance. However, on a population level, even 
small changes in cognitive abilities are of importance as this may impact the frequency of 
children falling below the limit for intellectual disability. Importantly, it has been estimated 
that 200 million children under five years in the world do not reach their full cognitive 
developmental potential due to preventable factors such as nutritional deficiencies 
(Grantham-McGregor et al. 2007). Indeed, the results from paper I and III add support for 
interventions promoting better nutrition and education. As stated by others, “Interventions to 
promote early child development are cost-effective investments to ensure that children are 
prepared for educational and economic opportunities […]” (Engle et al. 2007).  
5.1.2.2 Indicated toxicity 
At both 5 and 10 years, there were indications of non-linear associations between childhood 
selenium status and cognitive abilities (Figure 11). However, it should be noted that there 
were few children with concentrations above the indicated turning points (n=18-34). Even so, 
the non-linear associations seemed to have the same turning point at both 5 and 10 years 
(around 34 µg/L in urine), and was also present when using hair selenium at 10 years (more 
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long-term marker; turning point at 665 µg/kg). Using the equation for predicting hair 
concentrations from plasma concentrations found in paper IV (discussed under section 
5.3.1), a hair concentration of 665 µg/kg would correspond to 174 µg/L in plasma. However, 
this is extrapolated beyond the range of plasma selenium for the children included in paper 
IV, and it should therefore be interpreted with caution. For the association between urinary 
selenium at 5 years and cognitive abilities at 10 years, there was also an indicated turning 
point at 34 µg/L, however, the spline model and linear model were not significantly different 
in goodness of fit.  
When comparing these finding to others (Table 6), we found a Canadian study reporting an 
inverse association between children’s blood selenium and the latency of visual evoked 
potentials. However, the children had very high selenium concentrations (mean whole blood 
concentration: 331 µg/L; Saint-Amour et al. 2006), and the study included only 78 children. 
In addition, the inverse associations in paper III included only 18, 20, or 34 children (above 
the turning points), why this need to be more thoroughly assessed in future studies.   
Taken together, there are indications that the relationship between selenium status, both 
prenatal (as discussed in section 5.1.1) and during early childhood, and neurodevelopment 
could be non-linear. Indeed, it is known that selenium may act as a pro-oxidant at high intake 
(Lee and Jeong 2012), which may be the reason for the inverse associations. Indeed, 
recommendations of selenium supplementation, especially in the form of pills, should always 
be accompanied by information about the risk of toxic effects at over-dosing. More is not 
always better. 
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Table 6. Summary of studies on childhood selenium status and cognitive/motor/neurological abilities.  
+ positive association, - inverse association, / no association Abbreviations: cr, creatinine; IQ, Intelligence quotient; PKU, phenylketonuria 
Country Age Selenium assessment n Results Comments Reference 
Bangladesh 5 and 10 
years 
Urine: mean 14 and 15 µg/L at 5 
and 10 years 
Hair: mean 487 µg/kg at 10 years 
1167-1330 + 
/ 
- 
Positive association with cognitive 
abilities at both 5 (non-significant) 
and 10 years (significant). 
Indicated non-linear associations at 
both ages, turning point at 34 µg/L 
for urine and 665 µg/kg for hair. 
Paper III 
Bangladesh 9.6 years Whole blood: mean 104.9 µg/L 299 + 
/ 
Positive associations with motor 
function. No significant association 
for remaining 4 outcomes. 
Population highly exposed to 
arsenic. 
Parvez  
et al. 2011 
Brazil 15-87 
years 
Plasma: mean 163 µg/L;  
Hair: mean 840 µg/kg;  
Urine: mean 57 µg/g cr;  
Whole blood: mean 288 µg/L 
448 + Positive associations between plasma 
selenium and motor functions. 
Associations stronger when 
adjusting for blood mercury. Only 
significant associations in stratum 
with high mercury.  
Lemire  
et al. 2011 
  
Canada 4.8-6.2 
years 
Whole blood: mean 401.6 µg/L 110 / No association between selenium 
and motor function. 
Very high selenium concentrations. Despres  
et al. 2005 
Canada 4.8-6.1 
years 
Whole blood: mean 331 µg/L 78 - Positive association between blood 
selenium and latency. 
Very high selenium concentrations. 
Small sample size. 
Saint-Amour  
et al. 2006 
China 8-12 
years 
Whole blood: mean 94.77 µg/L 446 / No correlation between selenium and 
IQ. 
Analyses not adjusted. Sun  
et al. 2015 
Ethiopia 54-60 
months 
Serum: median 61.4 µg/L 541 + Cognitive deficits more common in 
selenium deficient children.  
Unclear whether analyses is 
adjusted for potential confounders. 
Gashu  
et al. 2016 
  
Democratic 
Republic of 
Kongo 
8.5 years Plasma:  
mean 30 µg/L 
123 cases 
87 controls 
+ 
/ 
Positive association between 
selenium and motor function in 
children with konzo. 
Spearman correlation used to 
assess association. No association 
with cognition. 
Bumoko  
et al. 2015 
  
Spain 9.7 years Plasma:  
mean 49 µg/L in PKU patients 
and 71 µg/l in controls 
36 cases, 29 
controls 
+ 
/ 
Positive association between plasma 
selenium and performance in PKU 
patients (attention, impulsiveness, 
response time, etc). 
No correlation between selenium 
and general intelligence in PKU 
patients. 
Gassio  
et al. 2008 
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5.2 MATENAL SELENIUM STATUS 
The mean erythrocyte selenium concentration at GW14 was 152 µg/kg (corresponding to 
0.45 µg/g Hb; paper III). Even though erythrocyte selenium is considered a valid, long-term 
marker of selenium status, there are no reference values established. For some of the women 
(n=98), we also had plasma selenium in early pregnancy, and the average concentration was 
60 µg/L (Li et al. 2008). This has been designated as low (Van Dael and Deelstra 1993), 
especially in relation to maximizing selenoprotein P, which occurs at higher concentrations 
(80-125 µg/L; Hurst et al. 2010). Even in relation to optimization of GPx3, which occurs at 
40-60 µg/L (Burk and Levander 2006), a large part of the women appeared to have low 
selenium status. As mentioned in section 2.1.5, this reasoning has lately been challenged, and 
the recommendations might be lowered in the future. To conclude, based on current cut-offs, 
a poor selenium status appeared prevalent among the pregnant women participating in 
MINIMat, as 60% of them had concentrations <60 µg/L, and 95% of them had concentrations 
<80 µg/L. However, it should be noted that such concentrations are also fairly common in 
many other countries, e.g. in large parts of Europe and south-east Asia (Figure 12).  
Figure 12. Selenium status across the world based on mean plasma concentrations among healthy 
populations. The cut-offs are suggested based on maximization of selenoprotein P; low (<80 µg/L), 
borderline (80-100 µg/L), adequate (>100 µg/L), and toxic (intake over 850 µg/day). Data from: 
Abdulah et al. 2013; Chen et al. 2006; Choi et al. 2016; Combs 2015; Gashu et al. 2016; Gibson et 
al. 2011; Golubkina and Alfthan 2002; Hagmar et al. 1998; Haldimann et al. 1996; Imai et al. 1995; 
Kishosha et al. 2011; Kornhauser et al. 2008; Kuehnelt et al. 2015; Lander et al. 2008; Lemire et al. 
2011; Li et al. 2008; Maduray et al. 2017; Pritchett et al. 2017; Schulze et al. 2014; Stoffaneller and 
Morse 2015; Van Nhien et al. 2006; FAO/WHO 2002; Saint-Amour et al. 2006.  
Adequate 
Low 
Toxic 
Borderline 
No data found 
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The Spearman correlation between the concentrations at GW14 and GW30 (overlap between 
paper I and III, n=444) was 0.44 (p<0.001), and the concentrations were lower in the third 
trimester (mean 144 µg/kg) compared to early second trimester (mean 158 µg/kg; p<0.001). 
Indeed, blood selenium has previously been shown to decrease during pregnancy, probably 
partly due to the demand of the fetus (Burk and Levander 2006). Surprisingly, we found no 
difference in erythrocyte selenium at GW30 by the different supplementation groups (paper 
I). The reason for this is unknown, but could be related to the absorption being lower for 
selenite than for organic forms such as selenomethionine (Roman et al. 2014). In addition, it 
is possible that the absorption is also affected by the combination of the 14 other 
micronutrients present in the pill.  
Using the plasma concentrations in early pregnancy in the sub-sample of women, we could 
also assess the relationship between erythrocyte and plasma concentrations. These were 
strongly correlated; rS=0.69, p<0.001 (paper I), and the best fitted equation (1) for the 
prediction of erythrocyte selenium from plasma selenium was the following:  
Erythrocyte selenium (µg/kg) = 2.47 x Plasma selenium (µg/L) + 25.5 (1) 
This implies that a plasma concentration of 60 µg/L (commonly used as cut-off for 
deficiency) would correspond to a concentration of 174 µg/kg in erythrocytes. Comparing 
this concentration to those of all women included in paper I (n=750, GW30) and III 
(n=1408, GW14) suggests that 92% and 75% were selenium deficient at the time of 
sampling, respectively.  
Unexpectedly, the urinary selenium concentrations appeared to increase across pregnancy, 
with the largest increase in early pregnancy (Figure 13). Possibly, this can be explained by 
the increase in glomerular filtration rate during pregnancy (Dunlop 1981). Also, we recently 
found that the relative concentration of TMSe decreased during pregnancy (Skröder et al. 
2018), implying that the production of other selenium metabolites (e.g. selenosugars) 
increased, which may be related to an upregulation of the one-carbon metabolism (Gardner et 
al. 2011). Such an upregulation would also increase the production of TMSe, and the 
concentration of this metabolite did in fact increase across pregnancy, although the relative 
amount decreased. Thus, this is an additional potential mechanism for the increased urinary 
selenium concentrations across pregnancy.  
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The correlation between the selenium concentrations in erythrocytes and urine in the sample 
of women with measurements at several time points throughout pregnancy (n=155) was very 
weak: rS=0.13 (p=0.11) at GW14, and rS=-0.086 (p=0.50) at GW30. The likely reasons for 
this poor correlation include the increased demand of the fetus, the increase in GFR, as well 
as the fact that urinary selenium is a short-term marker of selenium intake (days), in contrast 
to erythrocyte selenium (months; Thomson 2004). In particular the latter is supported by the 
fact that the correlation was stronger when comparing the urinary concentrations to the 
plasma concentrations at GW14 (rS=0.31, p=0.045) in the sub-sample of women described 
above (n=98), as plasma concentrations reflect intake over the past week/weeks (Hawkes et 
al. 2008). However, the correlation was still rather weak. This may be a result of the plasma 
volume expansion, which starts already between GW6-GW10 (Faupel-Badger et al. 2007).  
Nevertheless, given the indicated low selenium status in the pregnant women, and the implied 
importance of selenium for fetal brain development, it appears disadvantageous to increase 
the loss of selenium during pregnancy. The potential mechanisms and health consequences of 
this loss need further research.   
5.3 CHILDREN’S SELENIUM STATUS 
5.3.1 Biomarkers 
The urinary selenium concentrations in the children both at 5 (mean 14 µg/L) and 10 years 
(mean 15 µg/L; paper III) were quite low, but still higher compared to the mothers during 
pregnancy (mean 7.2 µg/L). Again, there are no cut-offs established for urinary selenium, but 
26 µg/L has been suggested to indicate selenium sufficiency as this has been found in 
selenium adequate areas (Högberg and Alexander 2007). At both 5 and 10 years, 95% of the 
children had concentrations below this value, which would indicate low selenium intake. 
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Figure 13. Urinary selenium concentrations across pregnancy 
among women who donated urine- and blood samples at all follow-
ups during pregnancy (n=155). 
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Thus, it was surprising to find that only 3% of the children with available plasma samples at 9 
years (n=223, paper IV) had concentrations below 60 µg/L (41% below 80 µg/L). A further 
discussion on factors influencing the biomarker kinetics in the children, including urinary 
excretion, is provided in the following section (5.3.2).  
The erythrocyte concentrations at 4.5 and 9 years (paper II and IV) were also higher (mean 
176 µg/L at 4.5 years and 189 µg/L at 9 years) than for the mothers even in early pregnancy, 
which does indicate a better selenium status in the children compared to their mothers. Part of 
the difference in selenium status between mothers and children is probably due to the 
pregnancy-related influences described above. Indeed, plasma selenium has been found to be 
approximately 20% lower among pregnant women, compared to non-pregnant (Neve 1991). 
However, it is also possible that the intake of selenium has increased over time. In support, 
the prevalence of stunting (HAZ<-2) was lower at 10 years (~28%) than at 5 years (~33%; 
paper III) and at 1.5 years (~49%), indicating better general nutritional status.  
When assessing whether hair could be used as a marker of internal dose of multiple elements 
(including selenium) for the present children (paper II), we found an overall correlation of 
rS=0.38 (p<0.001) between the selenium concentrations in hair and erythrocytes. In addition, 
the correlation was stronger for samples representing the time of blood collection (the 7th-8th 
cm of hair; rS=0.54, p=0.026). The mean selenium concentration in the children’s hair at 9-10 
years was 519 µg/kg (paper II, n=207) and 487 µg/kg (paper III, n=1330). The 
concentrations did not vary much within individuals (Figure 14; intraclass correlation 
coefficient=0.80, p<0.001), indicating low variation in selenium intake over time. 
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Figure 14. Element concentrations in hair from 19 girls analyzed in four sections of 2 cm each, 
counting from the head outwards. The left figure shows the concentrations of selenium along the 
hair, and the right figure the fold-change in geometric mean concentrations of all elements analyzed.  
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Hair selenium (as well as hair arsenic) did not seem to be markedly affected by external 
contamination. In contrast, the geometric mean concentration of manganese was almost 5-
fold higher in the sample 7-8 cm from the head, compared to the first 1-2 cm (Figure 14).  
One child in particular had very high manganese concentrations in all hair samples, and also 
in water used for both drinking and washing, but the concentration in erythrocytes was 
normal. We found strong associations between the arsenic concentrations in all media, but for 
the other elements, we found no/weak associations between hair and blood/urine, indicating 
that hair concentrations of these elements are not reflective of the internal dose. An 
illustration of the conclusions from paper II is shown in Figure 15.  
 
The literature including measurements of hair selenium is large, but there is no consistency 
regarding the relationship with e.g. plasma selenium. Studies have reported very different 
concentrations of hair selenium even at similar plasma selenium concentrations (Figure 16), 
which means that other factors may influence the selenium concentrations in hair (section 
5.3.2). In addition, a fairly recent JAMA-article showed that commercial laboratories (n=6) in 
the U.S. varied two orders of magnitude in their measurement of selenium in hair samples 
from the same person (Seidel et al. 2001), indicating influence from e.g. washing procedure, 
sample preparation and analytical method and performance. 
 
 
 
 
 
Figure 15. Summary of the findings from paper II. Selenium and 
arsenic in hair was found to represent the internal dose (concentrations 
in blood), while other elements in hair seemed to originate from external 
sources (dust or water).  
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For this reason, there are no established cut-offs for determining selenium deficiency, 
sufficiency, or toxicity, using concentrations in hair. The equation from the regression 
analysis in paper IV for hair and plasma selenium was as follows: 
 Hair selenium (µg/kg)=1.8×plasma selenium (µg/L) + 351   (2) 
This implies that for the present children, a plasma concentration of 60 µg/L would 
correspond to a selenium concentration of 459 µg/kg in hair.  
5.3.2 Biomarker kinetics 
Because of the observed uncertainties and discrepancies among the different biomarkers of 
selenium status used, we evaluated if any of all the available covariates could influence the 
selenium biomarker kinetics in the children (paper IV). Interestingly, we found that 
malnourished children seemed to retain more selenium (less selenium excreted in urine and 
more remaining in plasma), which is in line with the fact that selenium status is regulated 
through the urinary excretion (Robinson et al. 1985). Indeed, this is a likely explanation for 
the observation that only 3% of the children had low plasma selenium concentrations (<60 
µg/L), while 95% had low urinary concentrations, as discussed above. It has been speculated 
that selenium becomes available for excretion first when selenoprotein production approaches 
saturation (Burk and Hill, 2015).  
There is an important hierarchy of selenoproteins, both among the proteins and among 
tissues. At low selenium intake, the secretion of selenoprotein P from the liver to the plasma 
increases for maintenance of selenium transport to the most important tissues (Burk and Hill 
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2015), which may explain part of the higher P-Se in the malnourished children. In addition, a 
recent study on polymorphisms in genes related to selenoproteins indicated that humans 
living under selenium deficient conditions may adapt to such conditions (White et al. 2015). 
In fact, polymorphisms in such genes have been associated with both plasma and urinary 
selenium concentrations (Combs et al. 2011).  
Also, we showed, for the first time, that polymorphisms in INMT predicted concentrations in 
both urine and hair (but not the blood fractions), with higher concentrations among TMSe 
producers (INMT genotype AA or AG). This is in line with our findings among the pregnant 
women, for which we found no impact of INMT genotype on erythrocyte selenium 
concentrations (Kuehnelt et al. 2015). Still, potential health implications from being a TMSe 
producer and thereby excreting more selenium are currently unknown and should be studied 
further, especially since the frequency of producers was much higher in Bangladesh (33%) 
compared to Argentina (<5%) even though the selenium status was higher in Argentina 
(Kuehnelt et al. 2015). 
Other new findings were that both arsenic and cadmium exposure were predictors of 
selenium kinetics. For arsenic, higher exposure was associated with more selenium in the 
erythrocytes compared to other compartments (Figure 17). 
There are multiple mechanisms involved in arsenic-selenium interactions. As arsenic is a pro-
oxidant, the shift of selenium from plasma to erythrocytes with increasing arsenic exposure 
could be due to higher demand of GPx1, an antioxidative enzyme active in red blood cells. 
However, this needs to be further studied. The arsenic-selenium complex [(GS)2AsSe]- that 
has been shown to form in erythrocyte lysate from rabbits (Manley et al. 2006) is another 
possible explanation for this association. Still, as mentioned under section 2.4.1, this has 
never been identified in humans, and the toxicological importance of such a complex would 
need to be assessed, given that the main excretory route for both arsenic and selenium is via 
urine. 
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Unexpectedly, cadmium was one of the strongest predictors of the selenium biomarkers. In 
contrast to arsenic, cadmium exposure (cumulative exposure assessed as urinary cadmium) 
was inversely associated with selenium in erythrocytes and positively with selenium in urine. 
As cadmium, another potent pro-oxidant, accumulates in the kidney and increases oxidative 
stress in this organ (Matovic et al. 2015), it is possible that the demand of selenium in the 
kidney increases with higher cadmium exposure in order to increase the expression of GPx3, 
which is produced in the kidneys (Avissar et al. 1994). A study on mice recently showed that 
selenium, in the form of selenoprotein P and small selenium-containing proteins, is filtrated 
through the glomerulus and reabsorbed in the proximal convoluted tubule through megalin-
mediated endocytosis, and then used for production of GPx3 (Kurokawa et al. 2014). It has 
also been shown in vitro that cadmium may decrease the expression of megalin (Gena et al. 
2010). Thus, it is possible that the positive association between urinary cadmium and 
selenium is explained by decreased reabsorption of both elements in the proximal convoluted 
tubule.  
A large fraction of the variation in the biomarker selenium concentrations was still 
unexplained by the statistical models, most of which is likely explained by total selenium 
intake as well as sources and forms of selenium. 
The findings of the impact on biomarker kinetics by arsenic and cadmium, the exposure of 
which is frequently elevated in the study area from contaminated drinking water (arsenic) and 
high rice consumption [both arsenic and cadmium (Kippler et al. 2010; Kippler et al. 2016b)], 
may indicate that selenium status is overestimated  based on concentrations in erythrocytes or 
underestimated based on concentrations in urine. Also, the toxic exposures may increase the 
selenium requirement, for both mothers and children.  
5.4 POTENTIAL MECHANISMS OF SELENIUM IN CHILD DEVELOPMENT 
5.4.1 Thyroid function 
The importance of selenium for the function of the thyroid was first discussed when a 
condition known as myxedematous endemic cretinism (resulting in mental retardation, short 
stature, goiter, and hypothyroidism) was described in the Democratic republic of Congo. This 
condition was characterized by selenium deficiency (Goyens et al. 1987), and since this 
finding, the interest for the importance of selenium for this organ has increased. In addition to 
the brain, selenium levels are conserved in the thyroid during periods of low intake. In fact, 
the thyroid is one of the organs with the highest amount of selenium per g tissue, together 
with the kidney (Duntas and Benvenga 2015).  
The thyroid hormones are required already during the first trimester. However, the fetal 
thyroid function is not developed until gestational week 14-16 (de Escobar et al. 2004). Thus, 
the fetus is dependent on maternal thyroid hormones during the first trimester. After the fetal 
thyroid has started to produce these hormones, the fetus is instead dependent on maternal 
iodine and selenium for proper function. Still, the transfer of maternal T3 to the fetus is very 
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low (Velasco et al. 2018), and thus, the fetus is dependent on proper deiodinase function (and 
thereby selenium) also in early pregnancy, for the conversion of transferred T4. 
Patients and animals with mutations in the SBP2 gene, which encodes a factor essential for 
selenoprotein formation, are reported to have altered thyroid metabolism, reduced serum 
selenium and T3 levels, as well as deficits in motor coordination and mental ability (Pitts et 
al. 2014; Seeher et al. 2014). Also, selenium supplementation has been shown to be effective 
in treatment of several thyroid diseases (Ventura et al. 2017), although not in all studies (Mao 
et al. 2016).  
The activity of the deiodinases has been found to saturate at plasma concentrations of 65 
µg/L (Thomson 2004). In the small sub-sample of women with plasma selenium analyzed 
(n=98), 70% had concentrations below this level, suggesting that a large fraction of the 
pregnant women may have had an impaired thyroid function during pregnancy. However, the 
associations between maternal selenium status during pregnancy and children’s cognitive 
development appeared linear across the whole range of (erythrocyte) selenium 
concentrations, indicating either that the deiodinases saturate at higher concentrations in the 
present population, or that other mechanisms are also involved.  
In addition to selenium, adequate iodine is also essential for proper thyroid function, since 
this element is a component of T3 and T4. The two elements appear to collaborate in order to 
protect the levels of T3. In case of low iodine intake, iodine trapping increases, the synthesis 
of T3 is prioritized, and the conversion from T4 increases (Bougma et al. 2013). Therefore, 
the level of T3 is often not affected in many organs following low iodine intake. However, 
the brain seems to be more sensitive to low iodine status, and its levels of T3 falls below the 
normal even at mild iodine deficiency (Bougma et al. 2013). Thus, the conversion from T4 
might be extra important in this organ. We did not yet assess the combined impact of 
selenium and iodine status on cognitive abilities in the present population. Still, we adjusted 
the analyses in paper I for maternal urinary iodine measured in GW8 to eliminate potential 
confounding since both elements are present in fish. This adjustment did not markedly 
influence the estimate for selenium. In paper III, we did not include the iodine adjusted 
models since the number of women and children with urinary iodine measurements were 
somewhat fewer than the sample included. However, adjusting any of the models (prenatal, 
5-years cross-sectional, or 10-years cross-sectional) for urinary iodine at each respective time 
point did not have any major impact on the estimates for selenium (<1% difference between 
adjusted and unadjusted estimates). Importantly, it has been reported that when selenium and 
iodine deficiency are both present, correction of only the selenium deficiency has been 
associated with increased conversion of T4 to T3, which cannot be compensated by an 
increased T4 production due to the low iodine availability (Chanoine 2003). Therefore, it has 
been recommended that when intake of both elements is deficient, the iodine should be 
corrected prior to the selenium. 
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Figure 18. Scatter plot with smoothed lowess line for thyroid-
stimulating hormone (TSH) and hair selenium at 9 years of age. 
Unfortunately, we did not have measurements of thyroid hormones for the pregnant women. 
At 9 years, we did measure TSH in plasma available for 316 of the children in paper IV with 
hair selenium available. There was an indicated inverse association between hair selenium 
and TSH (Figure 18; implying better thyroid status at higher selenium concentrations), but 
unfortunately, it was not possible to analyze other thyroid hormones due to interactions with 
the Na-heparine from the tubes, why we could not assess this hypothesis further. Still, other 
studies on children’s thyroid hormones and selenium status have suggested that suboptimal 
selenium intake has only a modest effect on thyroid function (Chanoine 2003). 
5.4.2 Antioxidative protection 
Due to the high oxygen consumption of the brain, the production of ROS is particularly high 
in this organ (Roman et al. 2014). At imbalance with ROS-scavenging antioxidants, this can 
lead to oxidative stress, which has been associated with several neurodegenerative disorders 
(Roman et al. 2014). The developing brain is extremely susceptible to free-radical damage 
(Miller et al. 2012). Selenium, in the form of selenocysteine, is part of GPxs, which catalyze 
the breakdown of hydrogen peroxide. In addition, selenocysteine is also included in TrxRs, 
which are involved in the control of cellular proliferation and apoptosis through controlling 
thioredoxin activity and redox state (Fairweather-Tait et al. 2011). Besides GPxs and TrxRs, 
selenoprotein W, another selenoprotein with proposed antioxidative properties, is highly 
expressed in the developing as well as the adult brain, and the expression is maintained under 
dietary selenium deficiency in sheep and rats (Raman et al. 2013). The antioxidative actions 
of these proteins could be a mechanism for the observed, positive association between early-
life selenium status and cognitive development. The positive associations were present for 
most of the assessed outcomes in paper I and III, indicating a general protective effect, i.e. 
that selenium is important for several areas of the brain. This is in line with the experimental 
studies described in section 2.3.1, in which changes in expression of various selenoproteins 
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(e.g. GPxs) affected both motor- and various cognitive functions. In addition, selenoprotein 
W was highly expressed in >90% of the brain regions of mice, including cortex, 
hippocampus, and cerebellum, further supporting a general effect.  
In populations exposed to elevated levels of strong pro-oxidants such as arsenic and cadmium 
(Cuypers et al. 2010; Engstrom et al. 2010; Kippler et al. 2012a; Zwolak and Zaporowska 
2012), which is the case in the present studies, a counteraction by selenoproteins may be a 
potential mechanism for the positive associations between selenium status and cognitive 
abilities. However, in both paper I and III, adjusting for exposure to toxic elements (arsenic, 
cadmium, lead, mercury, and manganese) had marginal impact on the estimates, implying 
that the positive association between selenium and children’s cognitive abilities was 
independent of exposure to the toxic elements assessed. Still, many of the children in the 
present population are exposed to arsenic to a higher extent than most other populations (the 
range for the sum of iAs and its metabolites in urine samples from paper IV was 9-1268 
µg/L). Also, because of the rice based diet, cadmium exposure is higher than in many other 
populations, especially outside Asia. Thus, it is still possible that selenium could be of higher 
importance in populations with toxic exposures (especially pro-oxidants) compared to others, 
even though this was not evident from the adjusted analyses in the present study.  
5.4.3 Epigenetics 
The term epigenetics refers to alterations in gene expression that are not due to changes in the 
genetic sequence, but rather changes in the structure of the DNA. Such changes include 
DNA-methylation, histone modifications, as well as silencing by microRNAs. Epigenetic 
mechanisms are thought to be important in mediating the effects of diet on health and 
development. The most studied mechanism is DNA-methylation, during which a methyl 
group is covalently added to the 5-carbon of cytosine bases within CpG dinucleotides. This 
reaction is catalyzed by SAM-dependent DNA-methyltransferases (Anderson et al. 2012). As 
selenium is methylated prior to excretion, also using SAM as the methyl donor, it may be 
hypothesized that any competition for methyl groups would result in decreased DNA-
methylation with increasing selenium intake. Indeed, a cross-sectional study on human 
lymphocyte DNA found an inverse association between plasma selenium and DNA-
methylation in adults exposed to arsenic-contaminated drinking water in Bangladesh (Pilsner 
et al. 2011). Experimental studies, on the other hand, have shown that dietary selenium 
deficiency caused global DNA-hypomethylation of liver and colon DNA (Davis et al. 2000), 
and that selenium supplementation increases the DNA-methyltransferase activity (Davis and 
Uthus 2003). Thus, the impact of selenium on DNA-methylation is still unclear and further 
studies are warranted in this area, including studies on the effect of selenium on other histone 
modifications and microRNAs. 
DNA-methylation is of particular importance for programming during embryonic and fetal 
development. There appears to be no studies on the importance of selenium on DNA-
methylation in early life, but there are human studies that have found links between maternal 
folate status and other one-carbon nutrients with offspring DNA-methylation. The reported 
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associations were at specific loci, including imprinted genes, insulin-like growth factor 2, the 
paternally expressed gene 3 (PEG3), as well as genes related to brain development (Caffrey et 
al. 2018). To conclude, more studies are needed to clarify any potential role of selenium in 
epigenetic regulations of gene expression. 
5.4.4 Pregnancy outcomes 
As selenium has been associated with pregnancy outcomes such as gestational age at birth 
and birth weight (Mariath et al. 2011), it may be hypothesized that any effect of selenium is 
mediated through these pregnancy outcomes, since these may also affect brain development 
(Shenkin et al. 2004). Therefore, we included both birth weight and gestational age at birth in 
the analyses in paper I, and we also tried excluding birth weight to assess whether this 
resulted in any change in the estimate for selenium (no change observed). In paper III, we 
included birth weight in the 5-year analyses, and gestational age at birth in the 10-years 
analyses (based on the backwards elimination process for the two models). The positive 
association between erythrocyte selenium at GW14 and children’s cognitive development 
was present regardless of whether these factors were included in the model, and the estimates 
did not change by excluding them. Thus, the associations between selenium status in early 
life and cognitive development seem independent of birth weight and gestational age at birth, 
implying that the other mechanisms discussed above are more likely to be responsible for the 
positive associations.   
5.5 METHODOLOGICAL CONSIDERATIONS 
In all epidemiological studies there are strengths and limitations, and it is important to 
evaluate whether the findings are precise, valid, and generalizable. Bias can arise at many 
stages of a study, and are divided in random and systematic error. These types of bias, 
together with strengths of the studies in the present thesis, are discussed below.   
5.5.1 Strengths 
The strengths of the studies included in this thesis include the prospective design and the 
large number of participating mother-child pairs, the repeated comprehensive testing of child 
development, the many considered covariates, including HOME and maternal cognition, as 
well as measurement of selenium and other elements using a reliable ICP-MS method. In 
addition, the use of biomarkers is an advantage as this reflects the internal dose, which might 
not always be the case when the exposure is estimated from food frequency questionnaires. 
We also had several biomarkers for selenium (and other elements), assessed at several time 
points, which enabled evaluation and comparison of the biomarkers of selenium status over 
time in the present population. The available data on the children’s cognitive abilities at 
different ages strengthens the results, given the consistent findings over time. The ability to 
adjust for multiple potential confounders was also an advantage, as this shows robustness of 
the findings (see also section 5.5.3.3). The limitations of the studies included in this thesis are 
discussed in more detail in the following sections (5.5.2 and 5.5.3). 
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5.5.2 Random errors 
All uncertainties in any type of study are either due to systematic error or random error, 
where random error is related to the precision of all measurements and is reflected by the 
width of the confidence intervals. Since this type of error is random from one measurement to 
the next, it can be minimized by increasing the sample size (i.e. by averaging over a large 
number of observations). Paper I and III both included large samples (n=729 and 1408) of 
mother-child pairs, and thus, the random error is likely to be small in these studies. Indeed, 
this is indicated by the narrow confidence intervals, particularly in paper III. However, when 
stratifying by child gender, the analyses were indeed more imprecise. Despite stronger 
estimates among the girls (particularly in paper III), this difference was not statistically 
significant.  
For paper II and IV, the samples were smaller, and any random error might have been more 
influential in these analyses. Still, the main findings from these papers (e.g. the associations 
between selenium biomarker kinetics and arsenic and cadmium) appeared precise, and were 
also present at 4.5 years of age. Thus, the random error was likely small.  
As discussed under section 4.4.3, the analytical precision of all analyses of selenium and 
other elements was high (low CV% and LOD). For hair, the precision was somewhat lower 
than for the other media (Table 4). This was probably related to the many analytical runs that 
spanned over almost a year due to the large sample size and complicated procedure of sample 
preparation. Still, all samples were analyzed in a random order, and the large sample size 
(n=1330 in the final analyses) appeared to compensate for this variability (paper III). 
Regarding the cognitive outcomes, the inter-observer reliability was assessed both at 1.5, 5 
and 10 years, with intra-class correlation coefficients >0.85 at all time points, also indicating 
low random error.  
In addition to sample size, multiple testing also increases the risk of a type of random error. 
The papers in this thesis include a large number of analyses (multiple exposures and 
outcomes), which increases the risk of chance findings, i.e. type I error (incorrect rejection of 
the null hypothesis). However, the outcomes in the present papers (I and III) are not 
independent and the hypotheses were pre-defined (except for some predictors in paper IV), 
why this should not constitute a major problem. In addition, the main findings of this thesis 
(particularly paper III) were highly significant, indicating that they probably would have 
remained so even with false discovery rate adjustment of the p-values. The findings were also 
consistent over time, which also indicates that the risk of chance findings is low. Finally, 
incorrectly adjusting p-values for multiple comparisons may in contrast increase the risk of 
type II error (incorrect acceptance of null hypothesis).  
5.5.3 Systematic errors 
As opposed to random errors, systematic errors are not related to sample size, but rather 
depend on the ability to correctly measure exposure and outcome, and the ability adjust for 
relevant potential confounders.  
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5.5.3.1 Selection bias 
Selection bias may arise when the characteristics of the selected participants are different 
from those not selected, i.e. when the study sample is not representative of the population it 
was selected from. In paper I, we assessed whether the included participants (n=729 with 
selenium measurements) differed in any characteristic from those who participated in the 
follow-up at 1.5 years (developmental assessment) but were excluded from the study due to 
missing blood samples (n=1383). The participating mothers were older and had somewhat 
lower BMI and SES, although the differences for all factors were marginal. Other 
characteristics did not differ. This comparison has now been extended to all women enrolled 
in MINIMat (n=4436) and to all studies included in the thesis (Table 7). 
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 Table 7. Characteristics [mean ± SD (p-value from Wilcoxon signed-rank test)] of the whole study 
population and each sample used in the respective papers. N.A., not applicable. 
 
n in 
whole 
sample 
Whole study 
population 
(N=4436) 
Included in 
paper I 
(n=729) 
Included in 
paper II 
(n=207) 
Included in 
paper III  
(n=1408) 
Included in 
paper IV 
(n=395) 
Mothers 
     
Age (years) 4422 
 
26.3 ± 6.0 
 
26.7 ± 5.9 
(p=0.040) 
25.6± 5.9 
(p=0.052) 
26.6 ± 6.0 
(p=0.043) 
26.6 ± 6.0 
(p=0.40) 
BMI (kg/m2) 4435 
 
20.7 ± 14 
 
21.4 ± 23 
(p=0.0098) 
20.6 ± 3.0 
(p=0.19) 
20.6 ± 15 
(p=0.060) 
20.4 ± 2.9 
(p=0.13) 
SES 4436 
 
3.0 ± 1.4 
 
2.9 ± 1.4 
(p=0.0071) 
3.3 ± 1.4 
(p<0.001) 
2.9 ± 1.4 
(p<0.001) 
3.2 ± 1.3 
(p=0.011) 
Parity 4436 
 
1.7 ± 5.8 
 
1.5 ± 1.4 
(p=0.0062) 
1.2 ± 1.3 
(p=0.081) 
1.5 ± 1.4 
(p=0.0011) 
1.4 ± 1.3 
(p=0.17) 
Education (years) 4436 
 
5.0 ± 4.1 
 
4.4 ± 4.0 
(p<0.001) 
5.7 ± 3.8 
(p=0.017) 
4.6 ± 4.0 
(p<0.001) 
5.3 ± 3.9 
(0.10) 
Children 
      
Birth weight (g) 3267 
 
2690 ± 410 
 
2690 ± 400 
(p=0.48) 
2740 ± 370 
(p=0.083) 
2700 ± 390 
(p=0.69) 
2750 ± 410 
(p=0.0063) 
Gestational age at birth 
(weeks) 
3562 
 
38.7 ± 1.8 
 
38.7 ± 1.7 
(p=0.72) 
38.4 ± 1.6 
(p=0.0027) 
38.7 ± 1.6 
(p=0.17) 
38.7 ± 1.6 
(p=0.48) 
Mental development 
index at 1.5 years 2112 
78.8 ± 12 
 
78.1 ± 13 
(p=0.059) 
N.A 
 
N.A 
 
N.A 
 
Psychomotor 
development index at 
1.5 years 
2112 93.7 ± 13 
 
93.0 ± 14 
(0.021) 
N.A 
 
N.A 
 
N.A 
 
Comprehension at 1.5 
years 2038 
38.2 ± 7.7 
 
37.7 ± 7.5 
(p=0.030) 
N.A 
 
N.A 
 
N.A 
 
Expression at 1.5 years 2037 11.6 ± 6.9 
 
11.2 ± 6.5 
(p=0.28) 
N.A 
 
N.A 
 
N.A 
 
Verbal score at 5 years 2260 34.2 ± 12 
 
N.A 
 
N.A 
 
32.8 ± 11 
(p<0.001) 
N.A 
 
Performance score at 5 
years 2260 
34.7 ± 8.2 
 
N.A 
 
N.A 
 
34.1 ± 7.8 
(p<0.001) 
N.A 
 
Full score at 5 years 2260 82.4 ± 24 
 
N.A 
 
N.A 
 
79.2 ± 22 
(p<0.001) 
N.A 
 
Verbal comprehension 
at 10 years 1530 
36.7 ± 11 
 
N.A 
 
N.A 
 
36.7 ± 11 
(p=0.95) 
N.A 
 
Perceptual reasoning at 
10 years 1530 
32 ± 12 
 
N.A 
 
N.A 
 
31.8 ± 12 
(p=0.35) 
N.A 
 
Working memory at 10 
years 1530 
29.7 ± 6.1 
 
N.A 
 
N.A 
 
29.7 ± 6.2 
(p=0.63) 
N.A 
 
Processing speed at 10 
years 1530 
34.1 ± 12 
 
N.A 
 
N.A 
 
34.3 ± 12 
(p=0.26) 
N.A 
 
Full score at 10 years 1530 132 ± 33 
 
N.A 
 
N.A 
 
133 ± 33 
(p=0.41) 
N.A 
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The general characteristics of the included samples were comparable to all women and 
children included in the trial, although the included women generally had slightly fewer 
children. The similarities between characteristics of the samples and the whole study 
population indicate that no selection bias appears to have been introduced when defining the 
study samples, with regard to these characteristics.  
Selection bias may also arise if the exposure or outcomes differ between included and 
excluded participants. Although the cognitive outcomes could not be compared to the whole 
cohort (as cognition was not assessed in all children), they could be compared to the larger 
sample of children with these outcomes assessed (excluded due to missing sample for 
selenium analyses). At 1.5 years, a total of 2112-2037 children were tested, of which 729 
were included in paper I. The cognitive outcomes were slightly lower in the study sample, 
although the differences were very small (<5%). At 5 years, 2260 children were tested, of 
which 1408 were included in paper III. Again, the scores were somewhat lower in the study 
sample, with very small differences (<5%). Finally, at 10 years, 1530 children were tested 
and the included children (n=1408) did not differ from the excluded once (p>0.26 for all 
outcomes).  
As the children’s selenium concentrations in blood, urine, and hair were analyzed for each 
respective study it is not possible to compare the selenium status of included children to those 
in the whole study population. However, the children had a wide range of selenium 
concentrations in the different media, indicating that both selenium deficient and sufficient 
children were included in each study. For the maternal selenium status, we have measured 
erythrocyte selenium at GW14 for a total of 2375 women who are part of various sub-
samples of MINIMat (not included in this thesis). Comparing the selenium concentrations 
between the mothers included in paper I (662 women of the 729 included) and paper III 
(n=1408) to the remaining mothers (n=1713 and 967, respectively) showed that the 
concentrations were higher among women included in paper I (158 vs. 152 µg/kg), but lower 
for those included in paper III (152 vs. 157 µg/kg). Given that the difference was in opposite 
directions for the two studies, and that the average difference was <5%, it seems as though 
selenium status was not influential for participation. Thus, the risk of selection bias is likely 
small.  
As all pregnant women within the study area were invited to participate, and the participation 
rate was high, the whole study population of women included in MINIMat (n=4436) is likely 
representative of the whole study area. 
5.5.3.2 Information bias 
This type of bias arises when the exposure or outcome classification is incorrect. The use of 
biomarkers instead of estimated intake from food frequency questionnaires decreases the risk 
of exposure misclassification, since the internal dose is actually measured instead of 
estimated. As thoroughly described in section 4.4.3, we did not only have high precision in 
the selenium measurements, but also high accuracy (Table 4). Still, the variation between 
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analytical runs introduced some variation also in the selenium concentrations, however, this 
variation would be expected to be non-differential (random) and would likely drive effects 
toward the null. Even though the total selenium concentration in plasma or erythrocytes often 
correlate with the activity of many selenoproteins, analyses of the actual protein levels could 
have been useful both for confirmation of the selenium status, as well as for evaluation of the 
mode of action for the beneficial effects.  
Regarding the outcomes, they may indeed vary depending on the phycologist performing the 
assessment. However, as mentioned above, the inter-observer reliability was high, and all 
analyses were adjusted for tester. In addition, the testers had no knowledge as to the mother’s 
or children’s selenium status, and therefore any variation in outcome between testers should 
not influence the associations.  
5.5.3.3 Confounding 
When an association is due to factors that are associated with both the exposure and outcome, 
and not the investigated exposure itself, the reported estimates will become biased. To avoid 
this potential bias, all analyses of the present thesis were adjusted for a large number of 
potential confounders.  
It could be hypothesized that selenium might be a marker of general nutrition in the present 
population, and that a better general nutrition is driving the positive association between 
selenium and cognitive development. However, the associations were apparent also after 
adjusting for other essential elements (zinc, iodine, manganese) and hemoglobin, as well as 
BMI (mothers) or HAZ/WAZ (children; markers of chronic and current nutritional status). 
Still, it could be argued that since selenium is present in fish, the positive associations could 
be from long-chain fatty acids, also present in fish and known to be beneficial for brain 
development (Innis 2008). Unfortunately, there was no reliable information regarding dietary 
intake. To approach this issue, we measured the mercury concentration of children’s hair at 
10 years, which is known to be a good marker of fish consumption (Castano et al. 2015). 
Surprisingly, we found no correlation between selenium and mercury in the children’s hair 
(rS=0.01 p=0.75, n=1330). We also adjusted the analyses in paper III for the children’s hair 
mercury concentration at 10 years, and found no changes in the estimates for selenium. 
Furthermore, for a sub-sample of mothers (n=196) included in paper III, mercury had been 
measured in the erythrocyte fraction from GW14 (Gustin et al. 2017). In this sample, we also 
found only a weak correlation between erythrocyte selenium and mercury (rS=0.17, p=0.020). 
Thus, it appears as if fish is not the main source of selenium intake in the present population, 
and therefore, any residual confounding from fish consumption is likely low.  
As the main source of selenium in infancy is breast milk, and infant formulas have been 
found to contain low concentrations of selenium (He et al. 2018), it could be argued that the 
positive association between prenatal selenium status and cognitive abilities would be a proxy 
for the effects of breast feeding (Horta et al. 2015). We did not have very detailed information 
regarding breast feeding practice, why this was not included in the papers. However, the 
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women were asked whether they had breastfed exclusively for 4 months (yes/no), and we 
have now adjusted the analyses of paper I (information available for 482 out of the 729 
included mothers) and III (information available for 1402 out of the 1408 included mothers) 
for this variable. There was no difference (<5%) in the estimates for maternal erythrocyte 
selenium for associations with any outcome at 1.5, 5, or 10 years after this adjustment, 
supporting that the indicated effect of early-life selenium status was not confounded by breast 
feeding practice.  
Finally, the women enrolled in MINIMat did not smoke or drink alcohol, eliminating any risk 
of potential confounding from these lifestyle factors. 
5.5.4 Generalizability 
As shown in Figure 12, low selenium levels are common world-wide, why the findings of 
this thesis are of interest also for many other populations. We did not find any clear evidence 
of effect modification by factors such as BMI, SES, or birth weight, which indicates that the 
results may be applicable also to western populations. Still, the MINIMat study was 
conducted in rural Bangladesh, where maternal and child undernutrition is still common. The 
95th percentile of maternal BMI at GW8 was 25 kg/m2, indicating that even though there was 
no apparent effect modification, the variation might not have been large enough to detect 
such a modification. Indeed, the same theory is applicable to SES and birth weight, and 
therefore, the results of the present thesis might be generalizable to populations with poor 
nutrition in particular. In addition, the present population is commonly exposed to pro-
oxidants, especially arsenic and cadmium through the rice-based diet and contaminated 
drinking water. Thus, it is possible that selenium may be extra important in this population 
due to its antioxidative properties. However, millions of children around the world are 
heavily exposed to various pro-oxidants, other toxicants, as well as a poor diet.  
Some findings may, however, be applicable to most populations. The indicated inverse 
associations at the highest selenium concentrations are of particular concern for e.g. North 
America, where the selenium intake is much higher than in e.g. Bangladesh and Europe.   
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6 CONCLUSIONS 
This thesis points to the importance of selenium for cognitive development. In particular, 
adequate selenium status during pregnancy seems to positively influence children’s cognitive 
abilities even up to 10 years of age. Furthermore, children’s own selenium status also seems 
influential. This is of importance given that millions of people world-wide may be selenium 
deficient.  
The thesis also discusses strengths and limitations of different biomarkers of selenium status 
and intake, especially among children. New findings include confirmation of the use of 
selenium in hair (a long-term and non-invasive marker), as well as the shift in biomarker 
selenium concentrations upon exposure to certain toxicants, and the higher selenium retention 
in malnourished children. 
It should be remembered that high consumption of selenium can have toxic effects. 
Therefore, intake via food is preferred since it is more sustainable, most often less expensive, 
and decreases the risk of excessive intake. There were indications of inverse associations 
between selenium status and cognitive abilities among the present children with the highest 
selenium concentrations. High intake levels are common in e.g. the U.S. and Canada, and 
therefore also the inverse associations are of concern for other parts of the world and should 
be investigated further. In addition, the indicated non-linear relationship in the present thesis, 
together with findings from similar studies, further supports the suggested lowering of the UL 
for selenium intake.  
Finally, the results may be used by health professionals and authorities in motivating the 
public (parents in particular) to strive for a varied diet, thereby increasing the chance of 
reaching an adequate but non-toxic selenium status.  
 
 
  
  64 
7 FUTURE RESEARCH 
The studies and discussion included in this thesis provide evidence for selenium status being 
important for children’s cognitive development, but several questions remain. Future research 
should focus on the following:  
 Confirming the present findings using an experimental design that is focused on 
selenium, i.e. a randomized clinical trial, preferably in populations with low baseline 
selenium status, providing different selenium species at low to moderate doses.  
 
 Establishing whether the impact of early-life selenium status on cognitive 
development is indeed non-linear, and if so, identify the turning point.  
 
 Studying the mechanisms invoved in both the positive and negative effects, e.g. 
through inclusion of markers for thyroid function, epigenetic changes, and oxidative 
stress.  
 
 Investigating the role of the many selenoproteins with functions that are still 
unknown. 
 
 Evaluating to what extent the relationship is dependent on other factors, such as 
exposure to pro-oxidants or malnutrition.  
 
Regarding interactions with other elements, the assumed complex between selenium and 
arsenic (GS2AsSe)- should be attempted to be confirmed in humans. If present, the 
toxicological importance and excretory route of such a complex should be assessed. 
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8 POPULAR SCIENCE SUMMARY 
Deficiency of essential minerals is common world-wide and may lead to serious diseases. 
One of those minerals is selenium, which is found in food items such as meat, fish, and 
cereals. A daily intake of selenium that is too low is very common in Europe and large parts 
of Asia. This is due to the low selenium content in the soil, leading to a low content also in 
plants and animals that we eat. 
It has been known for some time that selenium is important for the immune system, fertility, 
and for the cardiovascular system. However, the interest has lately grown for the importance 
of selenium for the function of the brain. Among elderly, it has been shown that selenium 
deficiency is common among people with dementia diseases such as Alzheimer’s and 
Parkinson’s, but also among those with milder forms of dementia. The results from these 
studies suggest that selenium might be important for the cognitive functions of the brain, 
which are functions involved in thinking, knowing, remembering, and processing of 
information. However, it is still unknown whether selenium is important for the brain 
function also early in life, e.g. already during childhood or even fetal stages when the brain 
starts to develop.   
The aim of this thesis was therefore to investigate if selenium is important for proper 
development of the cognitive functions of the brain, and to study if this is particularly 
important during certain periods of development. To do this, we measured selenium in 
biological samples collected from pregnant women in rural Bangladesh. These women 
participated in a large micronutrient supplementation study, including 4436 women, recruited 
in 2001-2003. Once their children were born, they were followed-up on several occasions 
until 10 years of age, and biological samples such as blood, urine, and hair, were collected 
also from them. During visits to the health care facilities, their cognitive functions were also 
assessed by testing of their motor skills, language development, memory, and problem 
solving at both 1.5, 5, and 10 years. The results from such tests are often used to calculate IQ.  
We measured the amount of selenium in the biological samples collected from the mothers 
and children. The amount of selenium in different biological samples reflects the selenium 
intake over the past days (urine) or months (blood and hair). After statistical analyses, 
controlled for factors that may affect development, such as stimulation at home, 
socioeconomic status, growth, and schooling, it turned out that children born to mothers with 
more selenium in their blood during pregnancy performed better on the cognitive tests both at 
1.5, 5, and 10 years of age. Also, children who themselves had higher selenium intake 
(assessed through the amount in hair) performed better than others at the tests at 10 years, 
although there was an indication that too much selenium may be dangerous to the brain.  
To summarize, this thesis provides new knowledge regarding health effects of selenium early 
in life. The results indicate that adequate selenium is important for brain development and 
function, but that the limit for toxic effect may be lower than expected. This knowledge can 
be used in future revisions of the nutritional guidelines, but should be confirmed by others.  
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Brist på livsviktiga mineraler är vanligt förekommande över hela världen och kan leda till 
allvarliga sjukdomar. Ett sådant mineral är selen, som finns i bland annat kött, fisk och olika 
sädesslag. I Europa och stora delar av Asien är det vanligt att befolkningar har ett för lågt 
intag av selen. Detta beror till stor del på att det finns för lite selen i jorden, vilket gör att 
växter och djur som vi sedan äter inte innehåller tillräckligt med selen för att fylla vårt 
dagsbehov.  
Sedan tidigare vet man att selen är viktigt för immunförsvaret, fertilitet och för hjärta och 
kärl, men på senare tid har betydelsen av selen för hjärnans funktion också studerats. Hos 
äldre har man sett att brist på selen verkar vanligt hos individer med demenssjukdomar som 
Alzheimers och Parkinson, men också vid mer lindriga demenstillstånd. Resultaten från 
sådana studier antyder att selen är viktigt även för hjärnans kognitiva funktioner, alltså de 
processer som involverar tänkande, minne, vetande och hantering av information. Vad man 
dock inte studerat tidigare är om selen är viktigt för hjärnans funktion och utveckling redan 
tidigt i livet, såsom under barndomen eller under fosterstadiet när hjärnan börjar utvecklas. 
Målet med denna avhandling har därför varit att undersöka om selen är viktigt för 
utvecklingen av hjärnans kognitiva funktioner, och att studera om det finns vissa perioder 
tidigt i livet då selen är extra viktigt. För att göra detta analyserades selen i biologiska prover 
som samlats in från gravida kvinnor i Bangladesh i samband med en större studie som 
påbörjades 2001 och inkluderade 4436 kvinnor. Efter att deras barn föddes följdes de upp vid 
flera tillfällen upp till 10 års ålder, och även från barnen samlades biologiska prover såsom 
blod, urin och hår. När barnen kom till hälsoklinikerna för uppföljning testades också deras 
kognitiva funktioner såsom rörelseförmåga, språkutveckling, minne och 
problemlösningsförmåga när de var 1.5, 5, och 10 år gamla. Resultat från sådana tester läggs 
ofta ihop och används för att beräkna IQ. 
I de biologiska proverna som samlats från mammorna och deras barn mättes hur mycket 
selen som fanns, vilket speglar hur mycket selen de intagit den senaste tiden. Beroende på 
vilket biologiskt material som används kan man uppskatta selenintaget de senaste dagarna 
(urin) eller de senaste månaderna (blod och hår). Efter statistiska analyser, kontrollerade för 
övriga faktorer som kan vara viktiga för utvecklingen såsom stimulering i hemmet, 
socioekonomisk status, tillväxt och skolgång, visade det sig att barn till mammor som hade 
mer selen i blodet under graviditeten presterade bättre på de kognitiva testerna både vi 1.5, 5 
och 10 års ålder. Även barn som själva hade högre selenintag presterade bättre på de 
kognitiva testerna, men det fanns också en antydan till att för mycket selen kan vara farligt.  
Sammanfattningsvis bidrar denna avhandling med ny kunskap om hälsoeffekter av selen 
tidigt i livet. Resultaten indikerar att tillräckligt intag av selen verkar viktigt även för hjärnans 
utveckling och funktion, men att gränsen för när selen blir giftigt kan vara lägre än förväntat. 
Denna kunskap kan användas vid revidering av näringsrekommendationer för selen, men bör 
även styrkas ytterligare av andra studier.   
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